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ABSTRACT PAGE 
In vivo small animal imaging has become an essential technique for molecular biology 
studies. However, requirements of spatial resolution, sensitivity and image quality are quite 
challenging for the development of small-animal imaging systems. The capabilities of the 
system are also significant for carrying out small animal imaging in a wide range of 
biological studies. The goal of this dissertation is to develop a high-performance imaging 
system that can readily meet a wide range of requirements for a variety of small animal 
imaging applications. Several achievements have been made in order to fulfill this goal. 
To supplement our system for parallel-hole single photon emission computed 
tomography (SPECT) based upon a 110 mm diameter circular detector, we have 
developed novel compact gamma cameras suitable for imaging an entire mouse. These 
gamma cameras facilitate multi-head (>2) parallel-hole SPECT with the mouse in close 
proximity to the detector face in order to preserve spatial resolution. Each compact gamma 
cameras incorporates pixellated Nai(TI) scintillators and a pair of Hamamatsu H8500 
position sensitive photomultiplier tubes (PSPMTs). Two types of copper-beryllium parallel-
hole collimators have been designed. These provide high-sensitivity imaging of 1-125 or 
excellent spatial resolution over a range of object-detector distances. Both phantom and 
animal studies have demonstrated that these gamma cameras perform well for planar 
scintigraphy and parallel-hole SPECT of mice. 
To further address the resolution limitations in parallel-hole SPECT and the sensitivity 
and limited field of view of single-pinhole SPECT, we have developed novel multi pinhole 
helical SPECT based upon a 11 0 mm diameter circular detector equipped with a pixellated 
Nai(TI) scintillator array. A brass collimator has been designed and produced containing 
five 1 mm diameter pinholes. Results obtained in SPECT studies of various phantoms 
show an enlarged field of view, very good resolution and improved sensitivity using this 
new imaging technique. 
These studies in small-animal imaging have been applied to in vivo biological studies 
related to human health issues including studies of the thyroid and breast cancer. A re-
evaluation study of potassium iodide blocking efficiency in radioiodine uptake in mice 
suggests that the FDA-recommended human dose of stable potassium iodide may not be 
sufficient to effectively protect the thyroid from radioiodine contamination. Another recent 
study has demonstrated that multipinhole helical SPECT can resolve the fine structure of 
the mouse thyroid using a relatively low dose (200 Ci). Another preclinical study has 
focused on breast tumor imaging using a compact gamma camera and an endogenous 
reporter gene. In that ongoing study, mammary tumors are imaged at different stages. 
Preliminary results indicate different functional patterns in the uptake of radiotracers and 
their potential relationship with other tumor parameters such as tumor size. 
In summary, we have developed a versatile imaging system suitable for in vivo small 
animal research as evidenced by a variety of applications. The modular construction of this 
system will allow expansion and further development as new needs and new opportunities 
arise. 
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A VERSATILE IMAGING SYSTEM FOR IN VIVO 




1. 1 Motivation of this project 
The rapid development of imaging techniques such as computed tomography 
(CT), magnetic resonance imaging (MRI), ultrasound imaging, optical imaging and 
radionuclide imaging indicates that in vivo small animal imaging has become an essential 
tool for molecular biology studies. However, requirements of spatial resolution, 
sensitivity and image quality are quite challenging for the development of small-animal 
imaging systems. The capabilities of the system are also significant for carrying out small 
animal imaging in a wide range of biological studies. Developing a suitable imaging 
modality for a biological lab needs integrative consideration of imaging agents, system 
performance, economy, expandability and compactness. The goal of this work is to 
develop and to apply a high-performance imaging system that can meet different imaging 
requirements for a variety of in vivo small animal studies. 
Radionuclide imaging includes single photon imaging (planar scintigraphy and 
SPECT) and positron emission tomography (PET). When compared to the 
instrumentation, sophisticated radiochemistry and relatively short half-lives of most 
radiotracers for PET imaging, single photon imaging based on collimated gamma 
cameras provides a complementary alternative with high performance. Different 
2 
collimators such as parallel-hole and pinhole collimators can be employed in a gamma 
camera, and each provides unique advantages. Parallel-hole collimation may provide high 
efficiency, acceptable resolution and better sampling completeness over a relatively large 
active area. Parallel-hole planar imaging is especially valuable for whole animal region of 
interest (ROI) quantitative analysis and distribution studies. Single pinhole collimator can 
have both high resolution and high sensitivity if the object is close to the pinhole aperture 
but with a reduced FOV. Multipinhole imaging has been demonstrated in several studies 
to be suitable for high-resolution (near or less than 1 mm) tomographic imaging with high 
sensitivity and enlarged field of view. According to individual imaging requirements for 
a specific preclinical study, researchers may require different modes of collimation. If the 
required mode is readily available, the inconvenience of changing collimators and 
frequently re-calibrating detectors will be dramatically reduced during biological studies. 
As one of the radioisotopes for single photon imaging, 1251 is an excellent choice 
as a gamma imaging agent because of its low energy (~35 keV) for radiation safety and 
relatively long half-life (~60 days) for longitudinal studies. Hundreds of ligands tagged 
with 1251 are commercially available and readily meet the requirements of a variety of 
molecular imaging studies. However, the low energy photons emitted by 1251 can result in 
poor energy resolution for gamma cameras and raise a challenge for the imaging system 
to achieve high resolution. Because of the relatively long half-life of 1251, the prolonged 
radiation exposure of tissues, particularly the thyroid, may require a relatively low 
administration dose. As a consequence, this may impose the need for high sensitivity 
from the imaging system in order to maintain image quality. Therefore, the performance 
3 
of the imaging system in both resolution and sensitivity becomes significant when a low 
dose of radiotracer is used in small animal studies. 
1. 2 Project overview 
This dissertation describes the development of a versatile compact gamma-ray 
imaging system incorporating multipinhole circular/helical SPECT, parallel-hole imaging 
(planar projection or tomography) and X-ray imaging as well. The system for in vivo 
small animal research using low doses of 1251 has been applied to preclinical studies of 
the mouse thyroid and mammary tumors, both of which potentially involve issues related 
to human health. 
Novel compact gamma-ray cameras [1] with parallel-hole collimation, sized 
particularly for mouse imaging have been developed and utilized in this work. Both 
phantom and mouse studies have demonstrated that such a compact parallel-hole detector 
is particularly suitable for imaging an entire mouse with balanced resolution and 
efficiency. A second compact gamma camera has been constructed and incorporated into 
the system to form a dual-head imager to reduce imaging time. This dissertation deals 
particularly with an application study of gamma-ray imaging in detecting and 
characterizing mouse breast tumors in vivo with the sodium iodide symporter (NIS) as the 
reporter gene. In that study, one of the compact gamma cameras was employed m 
imaging breast tumors in mice infected with the mammary tumor virus (MMTV). 
A novel high-resolution, high-sensitivity multipinhole helical SPECT system [2] 
has been used by incorporating a 110 mm diameter circular detector equipped with a 
multipinhole collimator designed specifically for imaging the mouse thyroid region. A 
translation rack supporting the mouse bed, driven by a stepping motor along the axis of 
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rotation (AOR) of the system, has been implemented so that a helical trajectory is 
accomplished in additional to the conventional circular orbit. Phantom studies indicate 
the potential for an enlarged field of view, good resolution and enhanced sensitivity while 
employing a relatively low dose of the radioisotope 125I. Motivated by our earlier planar 
scintigraphy study of the blocking efficiency of potassium iodide in mice [2], a further 
study [3] has demonstrated the application of in vivo multipinhole helical SPECT in 
imaging the mouse thyroid using a moderate dose ( ~ 200 11Ci) of 1251. These results 
suggested potential applications in molecular imaging of other NIS-expressing tissues 
such as mammary tumors. 
1.3 Scope of this dissertation 
Since imaging system development is a collaborative work, I summarize the 
process made here with focus on the work I have carried out. Though some of this work 
is now seen in other systems, it will be described here as part of the evolution of our 
imaging system. In the section on application studies, details are given of the imaging 
performance of the system and image analysis. It is beyond the scope of this dissertation, 
however, to interpret the biological implications of the imaging results. 
Following this introduction, Chapter 2 introduces the importance of in vivo small 
animal research and the role of radionuclide imaging in this field including single-photon 
imaging (planar scintigraphy and SPECT) and PET. Recent development of radionuclide 
imaging for small animal research is also reviewed in various aspects in Chapter 2. 
Chapter 3 describes those works in which I have taken part during the evolution of our 
imaging system with emphasis on my major responsibilities. The development of X-
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ray/Gamma-ray dual-modality planar imaging is first described followed by a discussion 
of simultaneous gamma-ray imaging based on a pair of 110 mm diameter circular 
cameras equipped with parallel-hole and pinhole collimators respectively. The last part of 
Chapter 3 focuses on the development and characterization of novel mouse-sized 
compact gamma cameras. Instrumentation of multi pinhole helical SPECT based on a 110 
mm diameter circular detector is described in Chapter 4 with efficacy validated by results 
of proof-of-concept phantom studies. The application of this imaging system in a mouse 
thyroid study is described in Chapter 5 including a study of the efficiency of stable 
potassium iodide in blocking the uptake of radioiodine in the thyroid of a mouse and in 
vivo multipinho1e helical SPECT imaging of the mouse thyroid. Presented in Chapter 6 is 
an imaging application of the system in the study of MMTV mammary tumors with 
preliminary results reported. Chapter 7 concludes the dissertation with a description of 
ongoing and prospective future work. 
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Chapter 2 
In vivo radionuclide imaging of small animals 
This chapter introduces in vivo radionuclide imaging techniques for small animal 
research and reviews recent developments in this field. Section 2.1 describes the 
significance of in vivo small animal imaging. Section 2.2 is an overall introduction of 
radionuclide imaging techniques for small animals. Two major techniques for 
radionuclide imaging of small animals: positron emission tomography (PET) and single-
photon imaging are reviewed in Section 2.3 and Section 2.4, respectively. This chapter is 
concluded with Section 2.5, a brief discussion of small animal radionuclide imaging. 
2.1 In vivo small animal imaging 
Small animals such as mice and rats are widely used in biomedical research and 
serve vital model systems for understanding organism development, determining gene 
functions, studying numerous human diseases, and developing new pharmaceuticals and 
therapies [ 4, 5]. Among the animal models, mice especially play a key role in biomedical 
studies with advantages of economy, rapid propagation and easy manipulation of the 
genome [6]. Genetically engineered mice mimicking human disorders are well-
characterized models for the fundamental and therapeutic studies of diseases. Rats are 
also a favored animal model, especially in the field of neuroscience because the surgical 
manipulation of their brain is relatively easy along with the historically cumulative 
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knowledge base of the rat brain [ 6]. Small animals are essential for preclinical studies in 
translation to human application. However, the potential of small animal models in those 
studies is not yet fully realized. One significant limitation has been the requirement of 
sacrificing the animal to obtain desired information. Many natural or perturbed 
biomedical processes under study are unobservable ex vivo, which sequentially results in 
less-precise results [7]. Longitudinal studies in a single animal are barely possible in this 
case, leading to increased statistical variability due to the large number of sacrificed 
animals required by the molecular-biologic assays in order to achieve meaningful 
outcomes [5, 6]. At the molecular level, the ex vivo method makes it a formidable task to 
understand the function of numerous genes in the context of complex organisms [8, 9]. 
These intrinsic drawbacks of ex vivo methodology urge investigation of the biological, 
cellular and molecular processes in living animals. 
With the increasing requirement to resolve such issues and the impressive 
development of imaging technologies, non-destructive in vivo imaging stands out as a 
powerful discovery tool and a substantial solution [10, 11]. Though many imaging 
techniques were initially designed for human studies, extension of those techniques to 
small animals makes it possible to acquire functional, quantitative and longitudinal data 
in addition to structural anatomic information in vivo [5]. The living animals can be 
studied non-invasively and thus repetitively. Therefore, the required number of animals 
can be dramatically decreased. The statistical variation brought by the inter-animal 
differences is reduced concurrently owing to the fact that each animal can serve as its 
own control [12]. Biomedical processes related to biochemistry, genetics and 
pharmacology are able to be revealed not only visually but also quantitatively and even 
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dynamically in more details [13, 14]. These outstanding advantages have made in vivo 
small animal imaging a very promising tool in drug discovery and development [5, 15], 
in human disease studies using animal models [ 4, 16], and in characterizing gene 
expression and protein function [9, 12, 17]. 
2.2 Radionuclide imaging for small animals 
Major modern imaging techniques for in vivo small animal research include 
magnetic resonance imaging (MRI), ultrasound biomicroscopy (UBM), X-ray computed 
tomography (CT), optical imaging, and radionuclide imaging. Among these techniques, 
radionuclide imaging has shown great promise in small animal imaging for in vivo 
biomedical studies. Radionuclide imaging is a technique detecting gamma rays resulting 
from radiotracers injected and distributed in the body of a small animal. The radiotracer 
distribution may contain significant functional information at the molecular level such as 
gene expression and protein function. Therefore, radionuclide imaging is usually called 
functional imaging in order to distinguish it from other anatomical imaging techniques 
such as CT and MRI [18]. One may note that the recent development has extended MRI 
to functional imaging mainly in neuroscience, i.e. brain activity studies, by measuring 
cerebral blood flow/volume, blood oxygen level dependence or the level of manganese 
contrast agents associated with neuronal electrical activity [19]. However, non-
manganese-enhanced functional MRI in brain activity studies is usually carried out under 
anesthesia while, in the manganese-enhanced case, the usage of manganese agents is 
limited to small animals due to the concerns about toxicity [19]. With hundreds of 
biologically targeting ligands labeled with a variety of radioisotopes, radionuclide 
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imaging has played a key role in functional imaging and offers numerous opportunities 
for preclinical studies related to human health such as drug discovery, disease diagnosis 
and therapy. 
The production of gamma rays and the way to detect them divide radionuclide 
imaging into two categories: positron emission tomography (PET) and single-photon 
imaging. The latter can be further divided into two approaches: planar scintigraphy and 
single photon emission computed tomography (SPECT). Owing to the advances in 
detector instrumentation, imaging with both high resolution ( < 1 mm) and high sensitivity 
is possible now for either PET or SPECT. However, the major drawback of functional 
radionuclide imaging obviously is lack of anatomical information, which could be 
compensated by an anatomical imaging modality. 
Therefore, a combination of different modalities has been proved to be much 
more synergistic [20-22]. A typical example is to combine a functional imaging modality 
such as PET with another modality such as CT providing high-resolution structure 
information as reference for better interpretation of the molecular data. A variety of 
multi-modality imaging techniques for small animals has been developed or are under 
development including PET/CT, PET/MRI, PET/optical, SPECT/CT, SPECT/MRI, 
SPECT/optical, PET/SPECT/CT [10, 15, 23]. 
In the following sections, the methodology and recent development of 
radionuclide imaging for small animals will be introduced. This review will cover 




PET imaging utilizes the gamma rays coming from annihilation of an electron and 
a positron emitted from radioisotopes such as 18F and 11C. The electron-positron 
annihilation results in a pair of 511 ke V gamma rays emitted in opposite directions 
(approximately 180°), which are detected and paired by PET detectors (called a 
"coincidence event"). A line of response (LOR) can be formed making it possible to 
localize the source. When a PET detector has the response time of the order of 
picoseconds, it is possible to calculate the time of flight of the pair of gamma rays and to 
improve the accuracy in determining the source position along the LOR. All the 
coincidence events detected by a PET scan are grouped into projections which are sorted 
by view angles. Image reconstruction is then carried out based upon those projections. 
A nuihilation Image Reconstruction 
Siuognun/ 
Listmode Data 
Fig. 2.1 A diagram of a PET system. Image courtesy of Jens Langner [24]. 
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2.3.2 Detectors 
Two types of detectors are usually employed for PET imaging: scintillation 
detectors and semiconductor detectors. Scintillation detectors contain scintillators and 
photodetectors such as photomultiplier tubes (PMTs) or solid-state photodiodes. The 
properties of scintillators mainly including high density, high light yield and short decay 
time are important for achieving PET imaging with high spatial, temporal and energy 
resolutions. One of the most commonly used scintillators is Bi4Ge3012 (BGO). However, 
the long decay time (~300 ns) and relatively low light yield (9000 photons/MeV) make it 
not an ideal material for new generations of PET imagers, especially for small animal 
imaging. Therefore, other state-of-the-art materials for PET imaging have been developed 
typically including Gd2Si05:Ce (GSO), Lu2Si05:Ce (LSO), LuAl03:Ce (LuAP), YAP, 
Lm.sYo.2SiOs:Ce (L YSO, Saint Gobain Crystals), LFS (Zecotek Co.), and LaCb:Ce, etc 
[25, 26]. Listed in Table 2.1 are the properties of some typical scintillators for PET 
imaging with respect to density, light yield and decay time, etc. 
Density (g/cmj) Decay time (ns) Light yield(% Nal) Hygroscopic 
Nai 3.67 230 100 Yes 
BGO 7.13 300 15 No 
GSO 6.71 30-60 25 No 
LSO 7.4 40-43 75 No 
LuAP 8.3 183800 32 No 
LaCb:Ce 3.86 25 121 No 
LaBr3:Ce 5.3 23 160 No 
Table 2.1 properties oftypical scintillators for PET [25, 26] 
As conventional photodetectors for PET imaging, PMTs, especially position 
sensitive PMTs (PSPMTs) continue to be widely used owing to their high performance in 
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spatial and timing resolution. The compactness and high quantum efficiency have made 
semiconductor photodetectors such as position sensitive avalanche photodiode (PSAPD) 
a promising alternative for developing high-resolution animal PET system. A variety of 
new PMTs and photodiodes is available now such as the Hamamatsu R9779 [27], 
Photonis XP20DO [27], avalanche microchannel photodiode (AMPD) [28], micro-pixel 
avalanche photodiode (MAPD) [29], and the CMOS Geiger-mode avalanche photodiode 
(GPD) [30]. 
For a scintillation detector, the incident gamma rays are converted through 
scintillators to visible photons, which are measured by the photodetectors assembled with 
the scintillators. There are three ways to set up photodetectors with scintillators. The 
simplest configuration consists of a single plate of continuous scintillator and an array of 
photodetectors. In order to improve spatial resolution and reduce the cost per detector for 
PET imaging, the setup of a block detector has been developed by Jones eta!. [31] which 
consists of an array of four single-channel PMTs and a scintillator empirically cut into 
elements with various lengths. A more effective configuration for high-resolution PET 
imaging of small animals is to employ the position sensitive photodetectors with an array 
of small individual scintillators (0.8- 3 mm width and 5 to 20 mm length) [32]. 
With the advances of detector technology, semiconductor detectors based on 
silicon (Si) [33] or germanium (Ge) [34] have shown great promise for PET imaging of 
small animals. Unlike the scintillation detector with an interim conversion from gamma 
rays to visible photons, semiconductor detectors directly measure gamma rays by 
converting their photon energy into an electrical signal. Because Si and Ge detectors 
usually operate best at cryogenic temperatures, researchers recently have sought to 
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develop animal PET system using room-temperature compound semiconductor detector 
with high efficiency such as CdTe [35] and CdZnTe [36]. 
2.3.3 PET system design 
A PET system usually incorporates a number of detectors to effectively detect the 
coincidence events. There are three basic geometries found in dedicated PET systems [18] 
including hexagonal geometry of large-size detectors, full-ring geometry of a number of 
detectors with discrete scintillators, and rotating partial-ring geometry with fewer 
detectors. Depending on whether the axial collimation is employed or not, data 
acquisition of a PET system can be determined as a 2-D or 3-D imaging mode. For the 2-
D mode where axial collimation is applied, the LORs within each specific plane (direct 
plane) vertical to the axis of rotation (AOR) are considered. This mode results in the 
volume of the subject in each of those specific planes reconstructed individually. A stack 
of those reconstructed images forms the entire volume of the subject in the field of view 
(FOV). Since 3-D PET imaging uses no axial collimation, in addition to the direct planes, 
the LORs in other planes (oblique planes) in the system are also measured. This mode 
mcreases sensitivity and thus allows faster imaging. A disadvantage of this mode, 
however, is that more scattered events are detected after the removal of the axial 
collimation potentially degrading image quality. Also image reconstruction for 3-D PET 
becomes more computationally intensive owing to the larger size of the collected data in 
comparison with 2-D PET [37]. Development in software has helped to alleviate these 
issues [38, 39]. 
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2.3.4 Image reconstruction 
Image reconstruction for PET imaging can be divided into two types: analytic and 
iterative methods. The principle method for analytic image reconstruction is a Fourier 
transform-based backprojection algorithm. Image reconstruction algorithms based upon 
this principle have been developed for 2-D PET such as the filtered-backprojection (FBP) 
algorithm [40] and for 3-D PET such as the three-dimensional reprojection (3DRP) 
algorithm [ 41 ], respectively. The most widely used iterative methods for image 
reconstruction are based on expectation maximization (EM) algorithms [42] such as the 
maximum likelihood EM (ML-EM) algorithm and ordered subset EM (OSEM) algorithm. 
These methods, initially implemented in image reconstruction for 2-D PET, have been 
extended to 3-D PET [43]. Recent research related to image reconstruction focuses on 
developing faster algorithms such as re binning algorithms [ 44] and the techniques for 
better modeling the statistical properties of the noise for 3-D PET. In addition, 
corrections of attenuation and scatter for PET imaging continue to be an interesting field 
to improve the quality and accuracy of reconstructed images for PET (see reviews in 
[18]). 
2.3.5 Reported PET systems for small animals 
The dramatic advances in both hardware and software for PET imaging have led 
to the development of a variety of PET systems with sufficient resolution (0.8 - 2 mm) 
and sensitivity (0.1% - 7%) for imaging small animals such as mice [35, 45-56]. 
Summarized in Table. 2.2 are the recent developed PET systems dedicated for small 
animal imaging. As shown in the table, the most recent development of a "Fine Structure 
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Imaging PET scanner" has achieved sub-millimeter resolution (0.8 mm) full-width at half 
maximum (FWHM) for the first practical semiconductor scanner [35]. One may also 
note the appearance of systems capable of multi-modality imaging including PET/CT 
[57], PET/SPECT [58], and PET-MRI [59]. 
Systems Detector Transaxial Resolution· Sensitivity notes (center ofFOV, mm) 
ratPET BGO/PMT 2.3 1% [47] 
Sherbrooke PET BGO/APD 2.1 0.51% [51] 
MMIIPET LSO/PMT 1.3 >0.2% [48] 
ClearPET L YSO+Lu Y AP/PMT 1.3 08-1.5% r461 
YAP-PET YAP/PMT :::;2.0 1.7% [49] 
Tier PET YAP/PMT 2 0.1% r561 
MAD-PET II LSO/APD 1.1 2.8% [52] 
MicroPETII LSO/PMT 0.83 2.26% rss1 
MicroPET Focus LSO/PSPMT 1.69 7.1% [50] 120 
Explore Vista DR LGSO+GSO/PSPMT 1.6 4% [54] 
Mosaic GSO/PMT 2.2 1.3% [45] 
quadHIDAC PET HIDAC 1.0 1.8% [53] 
FSI-PET CdTe 0.8 4.1% r351 
* Transaxial resolution is defined as the reconstructed resolution measured in the 
transverse plane 
Table 2.2. A summary of PET systems for small animal imaging 
2.3.6 PET radiotracers and applications 
Many positron radioisotopes have been implemented in PET imaging. The 
properties (half life and energy) of those typical radioisotopes are listed in Table 2.3. A 
number of positron isotope-labeled radiotracers have been developed to target different 
biological or clinical issues [60]. The advent of modem animal PET systems along with 
the development of these radiotracers has facilitated studying those health or biological 
issues using small animals [18]. These studies focus on measuring glucose metabolism in 
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the rat heart and brain, studying the dopaminergic system in rat brain, and imaging gene 
expression. Particularly, the advantages of PET in functional imaging have made it a 
promising technique for oncology applications such as breast cancer study [18]. More 
detail in this respect can be found in Chapter 6. 
Radionuclide Half-life Energy (MeV) 
uc 20min 0.97 
UN 9.9 min 1.2 Do 122 sec 1.74 
liSp 110 min 0.64 
04Cu 12.7 hr 0.66 
MGa 68.3 min 1.9 
!L'IJ 4.15 day 2.1 
Table 2.3. Properties of PET radioisotopes [60] 
2.3. 7 Advantages and disadvantages of PET 
The most important advantage of PET is its exquisite sensitivity which can be as 
high as 7%. This easily facilitates researchers carrying out dynamic imaging studies by 
using PET scans of a few minutes. Short imaging time also reduces the problems 
resulting from other factors such as the animal's movement. Moreover, the available 
positron radioisotopes provide a variety of choices to develop ligands for different 
cellular targets. However, the properties of those positron isotopes also bring the 
disadvantages. Conjugation of positron isotopes to a wide range of molecules of interest 
may require sophisticated radiochemistry. Owing to the relatively short half-lives of most 
radioisotopes, preparation of radiotracers for PET imaging usually requires a nearby 
cyclotron and radiochemistry lab. Though 18F labeled radiotracers can be produced 
commercially off site now, it is necessary to frequently recalibrate the remaining dose 
and to plan the experiments much more carefully owing to its half-life of 110 minutes. 
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From economical point of view, the cost of PET system and imaging is expensive in 
comparison with SPECT. 
2.4 Single photon imaging 
2.4.1 Methodology 
Single photon imaging including planar scintigraphy and SPECT uses gamma 
cameras to detect the gamma rays emitted by radioisotopes such as 1251 and 99mTc. After 
the radiotracer is injected into an animal, the intensity and position information delivered 
by detected gamma rays from the distributed radiotracer may convey the information of 
biological or pathological interest to researchers. When the gamma camera images an 
animal following injection of a radiotracer, one can achieve a planar gamma image (or 
"projection") of the animal. This imaging method is called planar scintigraphy and is 
shown in the left panel of Fig. 2.2. Planar scintigraphy is useful for a number of studies 
such as determining the presence or localization of the radiotracers in some tissues 
(tumors, thyroid, etc.) or quantitative validation of the efficacy of some 
radiopharmaceuticals. However, since planar scintigraphy is a method of studying the 3-
D subject in 2-D space, useful depth information in the animal is lost along the direction 
vertical to the detector. SPECT has been developed to address that issue. SPECT allows 
researchers to study the animal in 3-D space. Instead of holding the detector at a fixed 
position, conventional SPECT takes a set of projections of the animal at a variety of 
evenly distributed angular positions. The 3-D distribution of the radiotracer in the animal 
is then reconstructed from the set of planar images by using an appropriate algorithm of 




As with PET, SPECT detectors can be divided into conventional scintillation 
detectors and semiconductor detectors. The scintillation detector originates from the 
gamma detector first described by Anger [61]. The procedure of scintillation detection of 
gamma rays is shown in the left panel of Fig. 2.2. When incident gamma rays at right 
angles pass through the collimators and strike the scintillator, they induce visible photons 
which can be detected by photodetectors such as PSPMT or PSAPD. The spatial 
information and number of counts of the detected incident gamma photons are able to be 
computationally determined to form a 2-D projection. This imaging procedure is almost 
identical to PET imaging except that a collimator is employed between the incident 
gamma rays and scintillators. Therefore, a modem scintillation gamma camera contains 
three critical components: photodetectors (PSPMT, PSAPD or CCD), scintillators and 




PSPMT Thansverse view 
Fig. 2.2 A diagram of conventional single-photon imaging system 
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Owing to the need for a collimator, one may instantly note that the sensitivity of 
SPECT detectors dramatically decreases in comparison with PET detectors where only 
axial or even no collimators are employed. Nevertheless, high resolution and/or relatively 
high sensitivity for small animal imaging can readily be achieved using gamma cameras 
equipped with appropriately designed collimators. A variety of collimators have been 
designed and implemented for single-photon imaging of small animals. Most of the 
collimators used are parallel-hole or pinhole collimators as shown in Fig. 2.2. Parallel-
hole collimators with square or hexagonal openings usually provide large FOV, high 
sensitivity and moderate resolution, which are sufficient for a number of studies. By 
incorporating a magnifying factor with a single pinhole collimator, one may achieve sub-
millimeter spatial resolution using a gamma camera with intrinsic spatial resolution in the 
order of millimeters. The geometric sensitivity Ps and spatial resolution Ra of a pinhole 
collimator can be expressed as [62, 63]: 
d cos3 m p = __..:;_e __ "f"~ 
s l6b 2 (2.1) 
(2.2) 
with the effective diameter de of the pinhole 
( )
1/2 
2 2d {)) de= d +-tan-
Jlc 2 
(2.3) 
Here, b is the distance between an object point and the collimator, cp is the incident angle 
of the photon, dis the diameter of the pinhole, w is the opening angle of the pinhole, Ri is 
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the intrinsic resolution of the detector, M is the magnifying factor employed for the 
pinhole collimation, and !lc is the linear absorption coefficient of the collimator material. 
As indicated in the equation, the smaller the diameter of the pinhole, the higher 
the geometric resolution ofthe pinhole collimator. However, this resolution improvement 
is achieved at the expense of considerably reduced sensitivity. Recently, several groups 
have demonstrated that novel multipinhole collimation substantially improves sensitivity 
while retaining outstanding resolution [64-66]. This achievement significantly extends 
the capabilities of SPECT to image small-scale tissues containing fine structure such as 
pancreas, thyroid and brain. In the past few years, new "slit-slat" collimation has been 
proposed to combine the pinhole's magnification in the transaxial direction with parallel-
or fan-beam's complete-sampling properties and large field of view in the axial 
dimension [67]. Such a collimation is especially suitable for imaging mice owing to its 
specific design. 
Position-sensitive PMTs have been widely used in modern gamma cameras. 
Owing to their excellent performance, a variety of PSPMT modules has been developed, 
tested and implemented for single-photon imaging mainly including Hamamatsu R5900 
[68], R2486 [69], R3292 [70], H8500 [1, 71], H9500 [72]. Recently, PSAPD modules 
have become promising photodetectors for developing scintillation gamma cameras. 
Several studies [73, 74] have been carried out to demonstrate the performance ofPSAPD 
modules produced by Radiation Monitoring Device (RMD, www.rmdinc.com). Some 
other studies show that a CCD-based gamma camera can be another promising alternative 
for single-photon imaging with high performance [75, 76]. 
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Common scintillators for single-photon imaging and their properties are listed in 
Table 2.4 [77]. The most widely used scintillator is Nal(Tl) which has an efficient light 
output (38000 photons/MeV). Since long decay time is of relatively less concern for 
SPECT in comparison with PET, Csl-based scintillators are also a good choice for 
SPECT imaging. While short decay time and high light output make LaBr3 a promising 
scintillator for developing time-of-flight PET, this scintillator is also of great interest to 
researchers developing SPECT detectors because of its high energy resolution [77 -79]. 
Density (g/cmj) Decay time ( ns) Light yield (% N al) Hygroscopic 
Nal(Tl) 3.67 230 100 Yes 
Csi(Tl) 4.5 1000 45 No 
Csl(Na) 4.51 630 85 No 
LaBr3(Ce) 5.3 23 160 No 
Table 2.4. Properties of typical scintillators for SPECT [77] 
As in applications to PET, room-temperature semiconductor detectors become 
promising and attractive as an alternative to conventional scintillation detectors because 
of their high energy resolution and compactness. Evaluation of detectors based on CdTe 
and CdZnTe (CZT) has been carried out [80, 81]. Results demonstrate the excellent 
performance of those semiconductor detectors suggesting their potential for small animal 
1magmg. 
2.4.3 SPECT system design 
Unlike PET, there is no need to pair gamma cameras inSPECT. This results in a 
diversity of configuration for SPECT systems. The conventional configuration is a 
rotation system with single/multiple detectors in a circular orbit that is positioned 
perpendicular to the axis of rotation (AOR). Both parallel-hole and pinhole collimation 
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have been implemented in such systems [68]. Effected by incorporating the circular orbit 
with the displacement of the object under investigation along the AOR, a helical orbit 
(helical SPECT) has been introduced to address the issue of sampling completeness in 
pinhole circular SPECT [67]. In contrast to such a rotating system, a stationary system 
has been developed using no detector rotation. Instead, movement of the object under 
investigation is required. A simple stationary configuration similar to a circular rotation 
system can be effected by rotating the object instead of the detector(s) [82]. The 
appearance of novel collimator technology has advanced the development of modem 
stationary configurations. One new configuration translates the object through the FOV 
of single/multiple stationary multipinhole detectors and is referred to as Translatory 
SPECT (T-SPECT) [83]. Another configuration (mouseSPECT) requires no rotation of 
the object but the collimator rotates to achieve complete tomography with stationary large 
annular detectors [84]. Complete stationary systems (USPECT-IIII and FastSPECT II) 
requiring no movement of detectors and the object have been developed by implementing 
both multiple detectors and multipinhole collimators [64, 85]. 
2.4.4 Image reconstruction 
As applied to PET imaging, the same principle algorithms i.e. analytic and 
iterative methods have been widely implemented in SPECT. Analytic methods have 
shown sufficient accuracy and efficiency for parallel-hole SPECT [86]. However, 
iterative methods gather more attention owing to both the complexity of implementing 
analytic methods in pinhole SPECT and the advent of fast computation including high-
speed computers and accelerated algorithms such as OSEM [87]. 
23 
A ML-EM algorithm for emission tomography (PET and SPECT) can be 
expressed as: 
A~n) d yjpij A~n+l) I 
L I d s 
LPij J=l LA~n) Pkj (2.4) 
J=l k=l 
where, i: 1, 2, ... , s; the labeling number ofvoxels in the object space for reconstruction 
j : 1, 2, ... , d; the labeling number of detectors. 
A,;n) : estimated radioactivity in ith voxel in the object space after n iterations. 
Pu :probability that a photon emitted by ith voxel is recorded by /h detector 
y 1 : number of photons recorded by /h detector 
As indicated in this equation, the key to reconstruct the unknown object space A,i is to 
determine the transition matrix p u . Li et al. has described in detail an analytic method to 
obtain each entry of this system matrix for pinhole SPECT imaging with a displaced 
center-of-rotation [88]. Siddon's ray-tracing technique has been implemented in that 
work in order to obtain the length of a ray in each voxel it intersects [89]. The 
experimental phantom tests have demonstrated that this method can effectively address 
the problems caused by misalignment of center-of-rotation. Corresponding to the analytic 
ways to determine system matrix p u , some groups have implemented more flexible 
numeric methods that can be easily adapted to complex pinhole shapes [66]. However, 
these numeric methods usually require higher computation resources. 
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2.4.5 Reported SPECT systems for small animals 
Based upon advances in gamma-ray imaging technology, several groups have 
developed novel imaging systems with excellent performance for small animal research. 
These systems have been built with PSPMT or PSAPD-based scintillation detectors or 
semiconductor detectors equipped with a variety of collimators including parallel-hole, 
pinhole, slit and slit-slat. A review in this section indicates that SPECT imaging with 
good resolution and good sensitivity has been the goal of much research. 
Parallel-hole SPECT continues to receive attention as a conventional imaging 
technology and a useful tool for biological studies. Kubo et al. have built a small animal 
SPECT system using CdTe semiconductor detectors equipped with a parallel-hole 
collimator. The achievement of high sensitivity and low scatter radiation by their system 
allows good quantitative analysis [90]. Owing to the increasing requirements of high 
resolution for small animal imaging, pinhole SPECT has received significant attention 
and development in the past several years. 
Qi et al. have reported a desktop single-pinhole SPECT system for small animal 
imaging with a high resolution on the order of 1 mm [91]. The same technology has been 
used in commercial animal SPECT systems, X-SPECT and A-SPECT, from Gamma 
Medica Inc [92]. As mentioned above, high resolution with single-pinhole SPECT is 
achieved at the cost of poor sensitivity. Small animal studies may require a high level 
injection dose or a long imaging time when using single-pinhole SPECT. Therefore, great 
interest has been given to the development of multipinhole SPECT. 
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Several groups have demonstrated the feasibility of multi pinhole SPECT in small 
animal imaging. Schramm et al [66, 93] presented multipinhole SPECT systems based on 
commercial gamma cameras and dedicated multipinhole collimators. They have carried 
out multipinhole imaging with high resolution as well as superior sensitivity based on 
commercial clinical equipment. In the recent report [93], they compared the performance 
of two multipinhole systems based on two commercial SPECT systems: a dual-headed 
Siemens ECAM and a triple-headed Trionix TRIAD. Both systems yield excellent 
performance in resolution and sensitivity. Lackas eta/. developed a translatory SPECT 
system with two orthogonal and stationary multipinhole detectors, taking advantage of 
the movement of the relatively low-mass object instead of the more massive detectors 
[83]. They recently reported progress on the development of a proposed dual-modality 
SPECT/CT system specialized for rat brain studies [94]. Compact commercial gamma 
cameras equipped with multipinhole collimators were incorporated with a cone-beam CT 
system for better orientation in SPECT images. An additional 3D translation stage 
facilitated helical scan orbit for both modalities. Their initial studies achieved a resolution 
about 1.2 mm for SPECT and 300!-lm for CT. Bioscan Corporation is now providing 
commercial NanoSPECT/HiSPECT systems based on the work of the Schramm and 
Lackas group. Meikle eta/. [65, 95] have reported a coded multipinhole SPECT system 
using detectors of their design based on Hamamatsu PSPMT modules. The performance 
has shown its suitability for certain high-resolution imaging applications in small animal 
studies. Using sixteen cameras, each of which was equipped with a single-pinhole 
collimator, Furenlid eta/. developed a completely stationary SPECT system (FastSPECT 
II) presenting great potential for dynamic SPECT imaging [85]. Beekman et a/. [ 64, 96] 
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proposed a novel stationary U-SPECT senes incorporating multipinhole collimation 
without multiplexing. The U-SPECT-I system incorporating 75 gold pinholes and 
standard Nai detectors had demonstrated a combination of ultra-fast, ultra-sensitive and 
ultra-high resolution. Their U-SPECT-II/CT system is commercially available now with 
even better performance. Goertzen et al. [84] designed and constructed a multipinhole 
SPECT system (called "mouseSPECT") with a stationary clinical scanner and a rotating 
collimator, which efficiently balances the resolution and sensitivity and has potential for 
dynamic imaging of small animals. Perterson et al. [97] reported the development of a 
multipinhole SPECT system equipped with silicon strip detectors. The results from their 
prototype system proved its feasibility for small field-of-view studies such as the mouse 
brain. Mok et al. [98] proposed a pinhole collimation system allowing flexible single-
and multi-pinhole SPECT of small animals of different size and achieving optimum 
imaging in terms of their size. Hesterman eta!. designed and built a novel multi-module, 
multi-resolution four-head SPECT system (M3R) for small animal imaging. This flexible 
system features interchangeable multipinhole plates for a variety of magnifications and 
pinhole configurations, which allows task-oriented system optimization for imaging 
applications [99]. Kim et al. developed the first full small-animal SPECT imager 
(SemiSPECT) based upon eight compact CZT detectors with high-intrinsic resolution. 
This achievement demonstrated the feasibility of simultaneous operation of multiple CZT 
detector arrays in a practical SPECT, which required solutions to issues including 
electronics, temperature control and mechanical assembly [100]. Funk et al. [101] 
designed a multipinhole SPECT system based on position sensitive avalanche photodiode 
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detectors (PSPADs). Their simulation results suggest submillimeter spatial resolution and 
potential for high throughput and low-dose SPECT imaging of small animals. 
To solve the axial blurring of circular-orbit pinhole SPECT, Metzler et a/. [67, 
102-1 05] reported the application of the helical orbit conventionally used in transmission 
computed tomography (TCT) to imaging with SPECT. They compared the difference of 
sampling completeness and its dependence on radius of rotation between a circular orbit 
and a helical orbit. A laser alignment system was designed and incorporated into the 
setup of a helical SPECT system based on a clinical scanner. Phantom studies and 
molecular imaging of small animals were carried out to demonstrate the capability of 
helical SPECT in accomplishing high resolution and high sensitivity without sacrificing 
sampling completeness. Their recent study evaluated the effect of angular-dependent 
axial-shift correction on the axial resolution of pinhole SPECT. Patil and Metzler [106] 
also compared the improvement in axial resolution between helical SPECT systems with 
step-and-shoot motion and continuous motion. Sun eta!. [107] have presented a helical 
SPECT scanner for small animals which features CZT detectors. Their initial results 
demonstrated improved axial spatial resolution and field of view (FOV). 
Other developments in small animal SPECT systems include slit SPECT and slit-
slat SPECT. Zeng eta/. reported their development of SPECT imaging using a CZT strip 
detector equipped with a slit collimator [108]. Preliminary phantom studies indicated that 
this system outperformed pinhole SPECT imaging with a larger scintillation detector. 
Metzler et a!. have recently re-evaluated the resolution and sensitivity of a slit-slat 
collimator [109]. Their results imply a possible niche for slit-slat collimation between 
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pinhole and parallel/fan beam collimation with improvements in sensitivity, resolution 
and sampling completeness [109]. 
To improve the accuracy in locating the radiotracer, dual-modality small animal 
imaging systems are also of interest. Hwang et a!. [11 0] are building a dual-modality 
system incorporating X-ray CT and microSPECT for small animal imaging. Hong et al. 
have reported a SPECT/CT system suitable for functional imaging of small animals with 
high-resolution morphology information [111]. By combining a low-field MR imager and 
a small animal SPECT system, Goetz eta!. [112] proposed a potential low-cost solution 
to achieve dual-modality imaging for preclinical studies. 
2.4.6 SPECT radiotracers and applications 
There is a range of radioisotopes used for SPECT imaging as listed in Table 2.5 
along with their properties. As mentioned before, 1251 is of particular interest to the work 
carried out here because of its low emission energy, long half-life, and commercial 
availability of a large body of 1251-tagged ligands. One disadvantage of 1251, however, is 
that the applicable dose of 1251 should be kept as small as possible while its half life 
broadens the time window for imaging. In addition to 1251-tagged radiotracers, a number 
of ligands labeled with other radiotracers such 99mTc and 1311 have also been developed. 
The large body of available ligands broadens the range of biological targets for SPECT 
imaging and provides a variety of opportunities to study biological or human health 
issues using small animals [86]. 
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Isotope Half-life Energy (ke V) 
'J'JmTc 6.02 hr 140 
lL:li 60.2 day 30 
1231 13.3 hr 159 
Ull 8.2 day 364 
lllln 2.8 day 171/245 
Table 2.5 Typical radioisotopes used in SPECT imaging [86] 
Small animal SPECT has been applied in a number of such studies. A substantial 
portion of these studies focuses on brain [113] and myocardium [114]. Using a mouse 
model, studies of renal function and inflammatory bowel disease have been carried out 
with dedicated SPECT systems [115]. Thyroid function and small-animal tumors are two 
areas receiving considerable attention [116] and are also of interest to the work described 
in this dissertation. Details about specific studies carried out in this project can be found 
in Chapter 5 and Chapter 6 respectively, including a re-evaluation of potassium iodide 
blocking efficiency and visualization of sodium iodide symporter (NIS) in the mouse 
thyroid, and an imaging study of mouse mammary tumors. 
2.5 Discussion of small animal radionuclide imaging 
Among all the available imaging techniques, radionuclide imaging has been the 
most important one to achieve functional information. PET has shown exquisite 
advantage in sensitivity. Recent breakthroughs in spatial resolution to submillimeter 
dimensions makes PET a promising modality for a wider range of applications. However, 
the half-life window of PET radiotracers can limit its application in measuring slow 
biological processes such as cell division occurring over hours or days [86]. The cost of 
PET imaging is relatively high considering system instrumentation and radiotracer 
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preparation. As a complementary approach, SPECT has shown considerable promise to 
meet imaging requirements in a number of preclinical studies. SPECT has unique 
capabilities to probe endogenous ligand interactions, to measure slow kinetic processes 
and to simultaneously probe multiple molecular pathways [86]. 
A diversity of SPECT systems has been developed with different performance 
owing to recent advances. Trade-off always exists among those systems regarding the 
FOV s, sensitivities, resolutions and costs. Different studies can have different 
requirements in those aspects and require adjustment accordingly. However, the available 
small animal SPECT systems are much less flexible and some are unable to make such 
adjustment readily. 
Recent development of multipinhole SPECT has provided new opportunities for 
high-resolution imaging of small animals with high sensitivity. The presence of the 
magnifying factor to improve spatial resolution, however, usually reduces the FOV of the 
detector. A helical orbit can extend the FOV along the AOR while improving sampling 
completeness of the pinhole collimator. Combination of multipinhole SPECT and a 
helical orbit thus provides a promising way to image large objects with high performance 
in resolution and sensitivity. 
The following chapters describe the development and application of a compact 
gamma-ray imaging systems which can readily meet a wide variety of imaging 
requirements for resolution, sensitivity and FOV. This system is the first one 
incorporating multipinhole circular/helical SPECT, parallel-hole imaging (planar 
projection or tomography) and X-ray imaging. In addition to the development of novel 
detectors, unique multipinhole helical SPECT has been incorporated into the system. The 
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system has been evaluated based upon phantom studies. Applications of this system to 
several biological experiments have demonstrated the efficacy and versatility of this 
system for in vivo small animal research. 
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Chapter 3 
Evolution of our imaging system 
This chapter describes the development of our imaging system in which I have 
participated during the past several years. Section 3.1 presents a description of dual-
modality imaging, which was achieved by incorporation of a small x-ray fluoroscope, 
followed by the development of simultaneous gamma-ray imaging with parallel-hole and 
pinhole collimation in Section 3.2. Section 3.3 details the calibration and performance 
evaluation of novel "mouse-sized" compact gamma cameras designed particularly for 
biological studies in the mouse model. Some results presented here have been published 
as journal articles [1, 117] or conference records [118, 119]. 
3.1 X-ray/gamma-ray dual-modality planar imaging 
As discussed in Chapter 2, multi-modality imaging combining functional imaging 
with anatomical information can facilitate better interpretation of functional data with 
precise structural detail. This is especially useful in gamma imaging when evaluating the 
physiological or pathological response of a small animal to a given radiotracer. The 
additional anatomical information will enable one to determine the organs or tissues 
where the radioactive compound is distributed. Therefore, in the early stages of this work 
we enhanced our gamma imaging system by incorporating a fluoroscopic X-ray 
apparatus (see Fig. 3.1) in order to achieve dual-modality imaging [117]. We seek more 
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precisely to identify the distribution and location of 1251-tagged compounds in the mouse 
through the fused image obtained by superimposing the anatomical X-ray image of a 
mouse with the gamma image. In order to validate the efficacy of this dual-modality 
planar imaging technique, we also carried out a proof-of-concept study of radioiodine 
uptake in mice blocked with stable potassium iodide (KI) in comparison with an 
unblocked control mouse. My major contribution to this work included data acquisition 
and performance evaluation of both gamma and X-ray imaging, design of the mouse bed, 
fusion of gamma and X-ray images, and their application in the proof-of-concept studies. 
Fig. 3.1 Photograph of the 1magmg system incorporating both gamma- and X-ray 
modalities [117]. 
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3.1.1 Performance of gamma and X-ray imaging 
The gamma camera employed in this work had been developed previously and is 
described elsewhere in greater detail [69]. Briefly, the 110 mm diameter circular detector 
was based on a Hamamatsu R3292 PSPMT module air-coupled to an array of pixellated 
Csi(Tl) scintillators, in which each crystal measured 1x1x3 mm3 with 0.2 mm separation 
between adjacent crystals. A 3 mm thick copper-beryllium parallel-hole collimator 
suitable for use with 1251 was employed in this work for high-resolution imaging. That 
collimator was fabricated of Cu-Be with 0.2 mm square holes separated by 0.05 mm 
walls. Programs developed with data acquisition software Kmax (Sparrow, Inc.) were 
implemented to obtain the raw data of gamma imaging. Those data were then analyzed 
using image analysis programs written in IDL language (Research Systems Inc.). 
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Fig. 3.2. A profile of the three hot spots in a one-hour gamma image. The phantom 
contained three spots with 15 mm spacing in a line. Each spot was loaded with 2 f..1Ci of 
125I [117]. 
We determined the resolution of the detector for 125I imaging using a three-spot 
source. Three 1 mm deep, small depressions with 15 mm spacing were drilled in a line in 
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a plastic plate measuring 50 x 50 x 3 mm3. Each spot was loaded with 2 J.!Ci of 125!. The 
three-spot source was placed 5 mm away from the collimator surface and imaged for one 
hour. Shown in Fig 3.2 is the profile of the three-spot source in the whole-hour image. A 
Gaussian fit to one of the peaks achieved a spatial resolution (FWHM) of just under 2 
mm. The measured efficiency of the detector using the same phantom was 70 ± 10 
cprniJ.!Ci. 
The small Lixi fluoroscopic X-ray apparatus [120] was employed for anatomical 
imaging of the mouse. This device has a 50 mm diameter effective view area. View area 
limitation necessitated making a composite view of the entire mouse with a series of X-
ray images. On the other hand, the small size of the X-ray equipment made it an excellent 
choice for easy incorporation into the existing gamma imaging system and development 
of a compact dual-modality imaging system for biological research. 
Fig. 3.3. A picture ofthe X-ray phantom made with CuBe and its X-ray image 
The performance of the fluoroscope was assessed by using the X-ray device to 
image a small copper-beryllium disk shown in left panel of Fig. 3.3. This disk contained 
36 
etched holes with a variety of diameters. The smallest hole was 100 11m in diameter. As 
demonstrated by the right panel in Fig. 3.3, the smallest holes could be clearly resolved 
indicating that our fluoroscope could provide a spatial resolution of 0.1 mm with 
potential for better results. 
3.1.2 Mouse bed and formation of the composite image of an entire mouse 
Formation of a composite X-ray image of an entire mouse required a reference for 
alignment of the successive X-ray images of a part of the mouse body. A specially 
designed mouse bed served not only to support the mouse during imaging but also as a 
useful tool for formation of the composite image. Presented in Fig.3.3 is such a mouse 
bed made with balsa wood. Fine nichrome wire is imbedded and serves dual purposes as 
both a heater to keep the animal at appropriate body temperature during the imaging 
period and a reference for alignment when making the composite X-ray image. For more 
precise alignment, 1 mm diameter metal spheres were also imbedded in a line on each 
longitudinal side of the bed at 1 em intervals. This design of the mouse bed ensured 
accurate, easy formation of the composite X-ray image of a mouse with negligible side-
effects from the nichrome wire and metal spheres in gamma and X-ray imaging. 
Fig. 3.4. Photograph of the mouse bed. Fine heating wires and 1-mm metal spheres were 
embedded for X-ray image alignment. 
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As Fig. 3.1 shows, the X-ray system positioned near the gamma cameras and the 
track supporting the mouse bed. When imaging, the anesthetized mouse placed on the 
mouse bed could be easily translated to an appropriate position for either gamma or X-ray 
imaging through the track. X-ray imaging was usually carried out immediately after 
gamma imaging of a mouse. A set of raw X-ray planar images from the Lixi fluoroscope 
was captured by a Canon G 1 digital camera with the imaging window of the device 
focusing on 5 to 7 consecutive areas sufficient to cover the whole body of the mouse. The 
data were then transferred and stored in a Macintosh G4 computer for further image 
processing. Using the image processing software Photoshop, each of the X-ray images 
was cropped and corrected for distortion based on the image of a fine metal grid. 
Thereafter, the group of processed images was visually overlaid with opacity of each 
image set to 45% by referring to both the imbedded nichrome heating wires and metal 
spheres. Examples of the composite image of a mouse are shown in the bottom frames in 
Fig. 3.5. 
3.1.3 Fusion of gamma-ray and X-ray images 
Once a composite X-ray image of the entire mouse was produced, it could be 
fused with the gamma image acquired prior to the X-ray imaging to form the dual-
modality gamma/X-ray image. However, such fusion requires reference points for co-
registration of these two different types of images. Reference points were needed near the 
mouse to be visible in both gamma and X-ray imaging in order to facilitate overlaying the 
two images precisely. Metal toroids of 2 mm inside diameter into which 1251 has been 
loaded play the key role as a reference for fusion of gamma and X-ray images. These 
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Fig. 3.5 Fusion of gamma-ray and X-ray images for unblocked (left) and KI-blocked 
cases (right), respectively. Each case contains a gamma image of the mouse on the top 
and a corresponding composite X-ray image at the bottom with their fused image 
presented in the middle [117]. 
fiducial marks were put in select positions of the mouse bed with negligible effect on the 
imaging and data analysis. Both the gamma camera and the X-ray device could readily 
observe these fiducial marks, which appeared as hot spots in gamma images and as dark 
rings in X-ray images (see Fig. 3.5). This allowed us to overlay gamma images on X-ray 
images easily and visually with opacity set to 30%-50%. The middle frames in Fig. 3.5 
show an example of the fused gamma/X-ray images. 
3.1.4 Proof-of-concept studies 
Potassium iodide (KI) is an FDA-recommended agent to protect the thyroid from 
accumulating radioiodine in the event of accidental release of radioactive contamination. 
The blocking effects ofKI have been reported and evaluated in a number of studies [121-
123]]. In order to validate the efficacy and demonstrate the utility of dual-modality 
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gamma/X-ray imaging in biological research, we carried out in vivo proof-of-concept 
studies of radioiodine uptake in mice blocked with Kl in comparison with control mice 
with no KI administered prior to radioiodine injection. A dose of 1% KI solution was 
administered orally to a mouse 60 minutes before the intramuscular injection of 4.8 1-1Ci 
of radioiodine (as Nai) into the same mouse. Both the KI-blocked and control mice were 
imaged for 60 minutes immediately following the administration of radioiodine. The 
distribution of radioiodine in both KI-blocked and unblocked cases was analyzed and 
compared to assess the blocking effects of stable KI in mice and the advantages brought 
by incorporation of anatomical information in gamma images. 
Presented in Fig. 3.5 are examples of unblocked (left in the figure) and KI-
blocked (right in the figure) dual-modality images. Top frames in Fig. 3.5 are gamma 
images obtained during 40-50 minutes post radioiodine injection. Bottom frames are 
composite X-ray images of the entire mouse. Central frames are fused gamma/X-ray 
images. The integrated images precisely indicate that major radioiodine uptake is located 
in the thyroid and stomach regions of the mice. As expected, a KI -blocked mouse 
presented much less uptake of radioiodine in the thyroid than an unblocked mouse. A 
significant portion of radioiodine was accumulated in the stomach region in either case. 
Greater detail about the difference between the two cases can be revealed through region 
of interest analysis [117]. 
Shown in Fig. 3.6 are the dynamic changes of the distribution of radioactive 
iodine in Kl blocked and unblocked mice over the first hour post injection. The three 
gamma images in each group in Fig. 3.6, from top to bottom, represent the radioiodine 
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Fig. 3.6. Gamma images presenting the dynamic change of radioiodine distribution in 
unblocked (left) and KI-blocked (right) mice. The time period from top to bottom were 0-
10 min, 20-30 min and 40-50 min post injection of 14 J..LCi Na125I. Here, sg stands for 
salivary glands, th thyroid, st stomach, fm fiducial mark, is injection site, and bl bladder 
[117]. 
distribution during 0-10, 20-30, 40-50 min imaging periods, respectively. With the 
precise anatomical information provided by dual-modality images (see bottom frames in 
Fig. 3.5), ROI plots can readily determine that most radioiodine was accumulated in the 
thyroid and stomach regions for the unblocked mouse over the time. However, the KI-
blocked mouse presented high quantity of radioiodine in the bladder and slow 
disappearance of radioiodine from the injection site as well as much less uptake in the 
thyroid. 
3.1.5 Conclusion 
By incorporating an X-ray imaging system into our gamma imager, we developed 
an imaging system capable of dual-modality planar imaging. The proof-of-concept 
studies validated the efficacy and demonstrated the advantages of dual-modality imaging 
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in biological research. This system allowed us to image temporal and spatial metabolic 
binding patterns in vivo of 125! -tagged radiotracers accurately with precise structural 
information [117]. Moreover, this real-time gamma imaging system provides a novel 
approach to address the concerns of KI -blocking efficiency and safety in both animal and 
human studies [117], and has been presented in a recently published paper [2] (see also 
Chapter 5). 
3.2 Simultaneous parallel-hole/pinhole gamma-ray imaging 
As indicated in Chapter 2, gamma imaging of small animals has been a promising 
technique in nuclear medical imaging with the capability of providing valuable functional 
information and potential application in biomedical studies. The dual-modality imaging 
described above has demonstrated the utility of planar gamma imaging with parallel-hole 
collimation. Planar imaging can expose the distribution of radiotracer in the whole body 
of a mouse. However, details about the distribution of radiotracer in a specific organ or 
tissue may still remain unclear due to the resolution of parallel-hole imaging in the order 
of 2 mm. Such details may be useful in studying the physiology or pathology of organs or 
tissues such as thyroid or stomach. As one of the methods for collimation, pinhole 
collimation is well known for its suitability for high-resolution imaging. In addition to 
parallel-hole imaging to obtain whole-body information of a small animal, simultaneous 
pinhole imaging focusing on a specific organ or tissue can help researchers to obtain 
organ- or tissue-specific information with greater detail at the same time. Furthermore, 
though planar gamma imaging continues to present utility in numerous biological studies, 
gamma-ray computed tomography, i.e. SPECT is becoming an effective tool to determine 
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the biodistribution of radioactive ligands in three-dimensional space. Researchers will 
certainly benefit from the information from an additional dimension by overcoming the 
potential ambiguity brought by planar imaging. A further development of SPECT 
imaging can significantly expand the capability of the imager in achieving tomographic 
information without sacrificing the animal. 
Fig. 3. 7, Imaging system incorporating two 110 mm diameter circular gamma cameras 
and a fluoroscopic X-ray apparatus. The top gamma camera was equipped with pinhole 
collimator while the bottom camera with parallel-hole detector [118]. 
For these purposes, we sought to accomplish simultaneous gamma-ray imaging 
with parallel-hole and single-pinhole collimation by using a pair of 110 mm diameter 
circular detectors. Attempts to facilitate SPECT imaging were also carried out. Presented 
in Fig. 3. 7 is the developed system incorporating two gamma cameras and a fluoroscopic 
X-ray apparatus. In this work, I have calibrated one of the gamma-ray detectors for 
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pinhole collimation equipped with a new pixellated Nai(Tl) scintillator, incorporated the 
detectors onto a cylindrical gantry for planar imaging or tomography, and carried out 
several proof-of-concept studies using this system. 
3.2.1 Gamma cameras for parallel-hole and pinhole imaging 
Both gamma cameras shown in Fig. 3.7 are 110 mm diameter circular detectors. 
The gamma camera for parallel-hole imaging has been described in subsection 3.1.1. In 
comparison with the parallel-hole gamma camera, the camera employed for pinhole 
imaging was also based on a Hamamatsu R3292 PSPMT module but was equipped with a 
crystal Nal(Tl) array of scintillators and a single-pinhole collimator. Described here is the 
calibration of the detector with the new scintillators employed. Detector calibration 
included three major steps: making the crystal lookup table, energy calibration and the 
uniformity correction. 
The scintillators were a circular array with a diameter of 88 pixels. In this array, 
each crystal scintillator pixel measured 1 x 1 x 5 mm3 with a pitch of 1.2 mm between 
two adjacent elements. Presented in the top panel of Fig. 3.8 is a raw crystal image, 
obtained by using high energy gamma rays ( ~ 660 ke V) emitted from a point source of~ 
15 1-1Ci 137Cs. The source was placed about 50 em above the detector surface and imaged 
for two days. No collimator was employed during this imaging. With the high energy 
gamma rays, nearly each crystal element could readily be identified. A crystal lookup 
table (see Fig. 3.8, bottom panel) was then generated using a program developed with 
Kmax software and this raw crystal map. When this two-dimensional lookup table was 
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Fig. 3.8 Raw crystal map ofthe scintillator array (top) obtained with~ 15 f.!Ci 137 Cs ( ~662 
ke V) and crystal lookup table (bottom) based on this raw image. 
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implemented back into the data acquisition program, the exact crystal element that a 
detected gamma ray intersected could be determined by examining the position of that 
gamma ray. When each of the detected gamma rays was mapped to a two-dimensional 
image by referring to the crystal lookup table, we were able to achieve a gamma ray 














Fig. 3.9 Normalized energy spectrum of~ 35 keV gamma rays emitted by 125!. The 
truncation in the spectrum is because the energy window was set to accept only photons 
from 28 keV to 53 keV. 
Since the crystal elements are not ideally identical and the response of the PSPMT 
not uniform, the energy response of the scintillators was not the same either. In order to 
obtain the best energy resolution of gamma imaging, an energy lookup table was 
necessary for energy calibration of individual scintillators. Because the energy response 
of the scintillators depends on the energy of gamma rays, the source selected for energy 
calibration should be the radioisotope, in our case 1251, intended for use in the biological 
studies. A point source containing 200 !JCi Na125I was placed about 1 meter away from 
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the face of the detector with no collimator. The imaging lasted about 4 hours. Using a 
specific Kmax program for energy calibration, the energy spectrum of each crystal 
element was determined and the maximum value of that spectrum was recorded. The 
energy lookup table is the vector containing the maximum spectral values of individual 
crystals. The energy of each detected gamma ray was calibrated by referring to this 
lookup table implemented in the data acquisition program. Presented in Fig. 3.9 is the 
energy spectrum of 3 5 ke V gamma rays of 1251 after the normalization. 
After both crystal and energy lookup tables were implemented, a flood imaging 
with a uniform source of the target radioisotope is required for correction of non-
uniformity ofthe detector. Unlike the case of parallel-hole collimation, the correction did 
not require the collimator to be employed for the case of pinhole collimation. The same 
point source for energy calibration (200 !J.Ci Na125I) was positioned 1 meter away from 
the surface of the detector and imaged 4 hours using the data acquisition program. The 
resulting image presented in the window "Image Full" was saved and implemented back 
into the data acquisition program for non-uniformity correction for future gamma 
imaging. This correction was automatically carried out by an embedded algorithm in the 
program. 
After detector calibration, we designed and built an aluminum barrel which 
allowed us to install the 110 mm diameter detector in combination with a pinhole 
collimator with a select magnifying factor. A tungsten collimator was employed 
containing an array of pinholes. Only the central pinhole was used initially with others 
shielded with 1.5 mm lead sheet, which was sufficient to block the 35 keV gamma 
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photons from 1251. The collimator was 6.5 em away from the surface of the scintillator 
array. 
3.2.2 Setup of the imaging system 
The cylindrical rotating gantry employed for setting up the imaging system has 
been reported previously [118] and is presented in Fig.3.7. Briefly, it measures 45 em in 
diameter and 11 0 em in length. The gantry can hold a variety of detectors such as 25 mm 
square or 110 mm diameter circular detectors and a Lixi fluoroscopic x-ray system [120]. 
Space exists for incorporation of additional compact detectors such as the "mouse-sized" 
detectors we developed recently [1]. The gantry can be rotated by a stepping motor (200 
steps per revolution) which can be controlled manually by a wired remote controller or 
automatically by a G3 Macintosh computer through the stepping motor driver Velmex 
NF90 (Velmex Inc.). The computer communicates with the driver via the RS232 
interface. 
Both parallel-hole and pinhole detectors are positioned onto the gantry face to 
face through mounting rings. The rings are easily be moved along the axis of the 
cylindrical gantry, which facilitates the easy focus of the pinhole detector on a specific 
region of interest of the mouse body while imaging the entire mouse with the parallel-
hole detector. The distance from the axis of rotation to either detector was 25 mm for 
SPECT imaging. A magnifying factor of2.6 was used for pinhole imaging. 
A 120 mm long Lexan tube placed horizontally at the center of rotation and in the 
field of view of gamma cameras and X-ray fluoroscope facilitates the transfer of the 
animal among the various imaging devices while supporting a custom-made mouse bed. 
The support tube with ~1.5 mm thick walls absorbs only ~7% of the 35 keV photons 
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from 1251. Its transparency allows easy positioning and visual monitoring of the animal. 
The tube can also serve a dual purpose of keeping the animal in stable condition with 
introduction of warmed, humidified air from one end and preventing contamination of the 
environment by exhaust of gases from the other end via a tube leading to a filtered 
exhaust system [118]. 
3.2.3 Image reconstruction for SPECT imaging 
The approaches to image reconstruction were based on the iterative maximum 
likelihood-expectation maximization (ML-EM) algorithm. The modified EM algorithm 
by Green [124] which was translated from its original C code into the IDL programming 
language by Steven Meikle was adopted for image reconstruction of parallel-hole 
collimation. A program (in Fortran) written by a member1 of our collaboration was used 
for image reconstruction of pinhole collimation. Sidden's ray tracing technique was 
implemented in both programs [89]. No attenuation correction was applied. The 
reconstruction used cubic voxels with edge length 1.2 mm. 
3.2.4 Simultaneous parallel-hole/pinhole planar imaging 
We carried out a proof-of-concept study to test this imaging method. An 
anesthetized mouse was imaged simultaneously with parallel-hole and pinhole 
collimation immediately following the injection of 14 f.!Ci Na125I. The pinhole detector 
was focused on the stomach region of the mouse. Shown in Fig. 3.10 are one-hour images 
from parallel-hole and pinhole detectors, respectively. The three hot spots in the parallel-
1 The program was written by Mark Smith 
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hole image were fiducial marks. One may note the consistency between the parallel-hole 
and pinhole images in the same region of the mouse body. Additionally, the magnified 
pinhole image reveals a clearer boundary and shape of the hot region in the mouse 
stomach area than does the parallel-hole image. 
Fig. 3.10 (Left) one-hour parallel-hole image of the entire mouse injected with 14 f.,tCi 
Na1251. (Right) one-hour pinhole image of the stomach region of the same mouse 
obtained with a magnifying factor of 2.6. Both images were achieved simultaneously 
[118]. 
3.2.5 Parallel-hole SPECT imaging - phantom study 
In order to verify the efficacy of our system for parallel-hole SPECT imaging, two 
studies were carried out with different phantoms. The two experiments were used to 
evaluate the trade-off between the imaging time and image quality, and the performance 
of parallel-hole SPECT for potential application to mouse thyroid imaging. 
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3.2.5.1 Experiment I- snake phantom 
Fig.3.11 Photograph of the snake phantom containing~ 20 ~-tCi Na125I. The top peak is 
about 25 mm and the second peak is ~ 13 mm. 
A series of SPECT tests has been carried out using a snake phantom illustrated in 
Fig. 3.11 to evaluate the interdependence between the imaging time and image quality for 
a fixed quantity of radioactivity. The phantom was made with a flexible plastic tube filled 
with ~20 ~-tCi 1251 source. The series of experiments with this phantom could be roughly 
divided into three groups based on their total imaging time: long-term(> 2 hours), short-
term (1-2 hours), and real-time (15 minutes). As listed in Table 3.1, the different imaging 
time resulted from the different combination of the angular increment around the AOR 
and the imaging time at each position. The results of four experiments are presented in 
Fig. 3 .12. All the slices presented here are at the same location of the phantom. 
Experiment #1 #2 #3 #4 
Angular increment 2 6 12 12 (degree) 
Imaging time 
at each position 8 5 2 30 
(mins) 
Total imaging time 24 5 1 1/4 (hours) 
Table 3 .1. Imaging parameters for the experiments using the snake phantom 
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Experiment #3 (1 hour) Experiment #4 (114 hour) 
Fig. 3.12 Reconstructed images of SPECT scans of the snake phantom using different 
imaging parameters. 
As the results indicated, long term SPECT imaging presented the best 
reconstructed image quality owing to better statistics. The reconstructed result of one 
hour imaging was less accurate and real-time (114 hour) imaging was the poorest in 
quality mainly due to low statistics. However, one may note that a relatively low total 
dose of 20 !JCi was used in these studies. A potential solution to achieve high-quality 
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imaging using short-term or possibly real-time would be to compensate the statistics by 
applying a relatively high dose of radioisotope. 
Fig. 3.13. Photographs of the plastic phantom simulating the thyroid and submaxillary 
glands of a mouse. The three voids, each containing~ 2 11Ci Na125I solution, were spaced 
2.5 mm from one another [118]. 
3.2.5.2 Experiment II - thyroid phantom 
The thyroid is an important biological system in a mouse. The size of the mouse 
thyroid and the spacing between thyroid and submaxillary glands provides an excellent 
test of SPECT imaging. Therefore, the experiment described here was to evaluate the 
performance of parallel-hole SPECT using a phantom simulating the structure of the 
mouse thyroid and submaxillary glands. The overall and end views of the thyroid 
phantom are presented in Fig. 3.13. In the phantom, three small cylindrical voids were 
drilled with their axes in the same plane and spaced 2.5 mm from one another. Each void 
was about 50 mm3 in volume and sealed with nylon screws after being filled with~ 2 f.!Ci 
Na125I solution. 
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The thyroid phantom was placed on the AOR of the imaging system with the 
plane containing three voids perpendicular to the A OR. SPECT imaging of the phantom 
was accomplished with an angular increment of 3° for 120 projections and 5 minutes 
imaging time at each angular position using the parallel-hole detector. Six reconstructed 
images are presented in Fig. 3.14 based on the data from this SPECT scan. The six 
images are consecutive along the AOR and present the tomographic information in the 
section of the phantom containing the three hot voids. Each slice is 1.2 mm thick and 
vertical to the AOR. 
Fig. 3.14. Six consecutive reconstructed images ofthe thyroid phantom. The parallel-hole 
SPECT scan was carried out with 3° increments and 5 minutes at each angular position. 
One may note that the central slices 3 and 4 clearly resolve the three voids 
separated by 2.5 mm (edge to edge), suggesting the reconstructed spatial resolution of the 
parallel-hole SPECT could be better than 2.5 mm. Moreover, the reconstructed voids 
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presented a structure consistent with their physical volumes. Particularly, the 
reconstructed image indicates that there has been some leakage of radiotracer along the 
threads of the nylon screw of the top void, which can also be visually observed in the end 
view of the phantom in Fig. 3.13. 
3.2.6 Single-pinhole SPECT imaging - phantom study 
A preliminary experiment has also been carried out usmg a three-capillary 
phantom to test the validity of single-pinhole SPECT. The three capillaries, each with 
about 16 ~Ci in 8 em, were parallel in three dimensions. One capillary was positioned on 
the intersectional line of two perpendicular planes containing the other two capillaries. 
Those two capillaries were 4 mm and 8 mm away from the first capillary, respectively. 
Single-pinhole SPECT scan was accomplished with an angular increment of 3° for 120 
projections and 3 minutes in duration. Presented in Fig. 3.15 are a planar image of the 
phantom and a transaxial image reconstructed from the SPECT data. 
Consistent with their physical spatial distribution, the three capillaries were 
properly reconstructed as demonstrated in Fig. 3.15. The three hot spots in the 
reconstructed image formed a right angled triangle. The perpendicular sides determined 
from the reconstructed image were about 4 mm and 8 mm, respectively. 
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Fig. 3.15 (Left) a projection of the 48 JlCi three-capillary phantom. (Right) a transaxial 
image of the phantom reconstructed from the data of a single-pinhole SPECT scan with 
3° increments for 120 projections and 3 minutes in duration. 
Further characterization of pinhole SPECT was accomplished later when we 
developed multipinhole circular/helical SPECT. Details are described in Chapters 4 and 5. 
3.2. 7 Simultaneous parallel-hole/pinhole SPECT- animal study 
Encouraged by the phantom studies, a preliminary proof-of-concept study of an 
animal was carried out using simultaneous SPECT imaging with parallel-hole and 
pinhole collimation. A mouse was injected with about 10 f.lCi of 1251 tagged insulin. One 
hour later the mouse was sacrificed and imaged with both detectors. The SPECT scan 
was 3° increments and 3 minutes of imaging at each of the 120 positions. The pinhole 
detector was focused on the stomach region of the mouse. 
Presented in Fig. 3.16 are reconstructed images of parallel-hole SPECT. The left 
two images in Fig. 3.16 are planar views at 0° and 180°, respectively. The three hot spots 
in those images are fiducial marks. The top and bottom image in the right panel of Fig. 
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3.16 are transaxial and sagittal reconstructed images, respectively. Both images indicated 
accumulation of 125!-tagged insulin in the stomach region as can be expected. 
Fig. 3.16. (Left two images) parallel-hole projections of the mouse injected with 10 J.tCi 
at oo and 180°, respectively. (Top-right) transaxial image of the mouse stomach region. 
(Bottom-right) sagittal image of the mouse reconstructed from the parallel-hole SPECT 
scan with 3° increments for 120 projections and 3 minutes of imaging at each angular 
position [118]. 
In contrast with parallel-hole SPECT, reconstructed results of single-pinhole 
SPECT scan presented poor image quality owing to low statistics. As previously noted, 
the mouse was injected with a relatively low dose of 10 J.tCi radiotracer. The accumulated 
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radioactivity probably is less than 1 j.!Ci in the mouse stomach. To obtain useful 
reconstructed images, a higher dose of radioisotope may be required, especially for short 
term imaging to monitor relatively rapid biological processes. 
3.2.8 Discussion and conclusion 
We have developed a versatile imaging system capable of simultaneous gamma 
imaging with parallel-hole and single-pinhole collimation. Preliminary planar imaging 
studies suggest the potential utility of this system in biological research for simultaneous 
investigation of the entire small animal and regions of interest of the animal. Further 
preliminary studies indicated that this imaging system is also promising for SPECT 
imaging of small animals. Reasonably high resolution (better than 2.5 mm) has been 
achieved with a dedicated parallel-hole collimator. However, the dose of radioactive 
ligands employed in the biological study needs to be optimized to achieve the balance 
between high imaging quality and short imaging time. One possible solution for parallel-
hole SPECT may be to employ an array of three or four detectors so that each detector 
only need rotate 120° or 90° to obtain the data set of a full 360°. In particular, due to the 
low sensitivity for pinhole imaging, a reasonably high level of radioactivity may be 
required in order to obtain high-quality image reconstruction for in vivo, real-time 
SPECT of animals. An alternative method to improve the sensitivity for pinhole SPECT 
while keeping its high resolution is to employ multiple pinholes, which will be described 
later in Chapters 4 and 5. 
This gantry setup also expresses great flexibility for future system development. 
The small fluoroscopic X-ray apparatus was readily installed onto the gantry to enable 
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dual-modality imaging. The mouse-sized compact gamma cameras we developed 
recently were easily incorporated as demonstrated in the following section. 
3.3 Development of compact gamma cameras for biological imaging 
As noted previously, an array of three or four detectors could substantially reduce 
imaging duration for SPECT while allowing a reduced does of radioactivity to be utilized. 
However, detectors based on the 110 mm diameter circular R3292 PSPMT modules may 
be not suitable for this setup. Though this type of detector has proved to be an excellent 
choice for large field-of-view imaging, it will not be cost-effective to incorporate several 
such detectors for parallel-hole SPECT imaging. The large diameter of these detectors 
will prevent them from providing a compact array in proximity to the subject animal or 
the AOR. For parallel-hole imaging, the spatial resolution of the detector at the AOR 
degrades with increased distance from the detector to the AOR. This will consequentially 
cause diminution of reconstructed spatial resolution of parallel-hole SPECT. Considering 
the high cost of a detector based on the Hamamatsu R3292 module and the difficulty to 
place several such detectors close to the subject animal simultaneously, we sought to 
develop a compact, economical detector suitable for imaging an entire mouse or specific 
organs with high performance. In comparison with the 110 mm diameter circular detector, 
this detector should be compact enough and must readily facilitate simultaneous use of 
three or four such detectors arranged in close proximity to the subject mouse for parallel-
hole SPECT imaging [1]. 
As indicated by the reviews in Chapter 2, the Hamamatsu H8500, a new 2 inch 
square PSPMT, has become generally available with promising performance [125]. 
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Building upon the reported research based on the H8500 PSPMT, we sought to develop a 
"mouse-size" compact gamma camera suitable for imaging an entire mouse, which also 
can facilitate parallel-hole SPECT imaging with small radius of rotation and permit use 
of several such detectors simultaneously [1]. My contribution in this work has been to 
calibrate and characterize the detectors, to design a new and more effective parallel-hole 
collimator and to evaluate the performance of the detectors based upon proof-of-concept 
studies. 
Two such compact detectors have been developed to date. The difference between 
them lies in the readout circuit and the collimator. The following sections describe in 
detail the calibration and performance evaluation of the first "mouse-sized" detector. 
Based on the results of the first detector, a new parallel-hole collimator providing better 
resolution with acceptable efficiency has been designed and manufactured for a second 
detector. The efficiency and resolution of the new collimator is compared with those of 
the initial collimator based on the second detector. 
3.3.1 Development of the first novel "mouse-sized" gamma camera 
Details concerning the design of this detector can be found in a report presented 
previously [1]. Parameters of this detector will be briefly described here. 
3.3.1.1 Summary of the first "mouse-sized" gamma camera 
This novel gamma camera was developed based on a pair of Hamamatsu H8500 
flat-panel PSPMTs. Each H8500 module measured 52 x 52 x 34 mm3 with a sensitive 
area about 49 x 49 mm2. The two tubes were placed side by side and optically coupled to 
a 36 x 80 array of Nal(Tl) scintillators. Each crystal element measured 1 x 1 x 5 mm3 
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with 0.2 mm reflective walls in between the scintillators. The outermost row of pixels 
was made 2 mm wide to add strength in the fabrication of the scintillator. The scintillator 
array was encapsulated with a 50 11m aluminum cover causing about 15% attenuation for 
~35 keV (125I) photons and included a 3 mm glass window faced to the PSPMT tubes. A 
5 mm thick CuBe parallel-hole collimator suitable for 125I imaging was employed with 
0.55 mm square openings and 0.11 mm septa. The active area of this collimator was 52 
mm x 105 mm. All the components of this detector including electronic readouts were 
assembled and contained in an aluminum box measuring 140 x 82 x 107 mm3. The 
assembled gamma camera is presented in Fig. 3.17 along with a sample collimator for 
such detector. 
Fig. 3.17. Photograph of the detector and a collimator identical to the one used in the 





Composiflex Entrance Window 
Fig. 3.18. The diagram ofthe inside view ofthe compact gamma camera 
3.3.1.2 Calibration of the compact gamma camera 
A diagram of a side view of the detector is presented in Fig. 3.18. One may note 
that an insensitive region ( ~ 3 mm width) exists in between the two H8500 PSPMTs, 
where there were no anode pads but only glass walls. However, the position information 
of a gamma photon entering the gap region could still be determined by referring to a 
crystal lookup table, which represented the geometric response region of the individual 
crystal elements [1]. In order to do that, a raw crystal map of the scintillator array was 
obtained using a high energy (662 keV gamma rays) point source 137Cs placed 150 mm 
above the detector. As shown in the left panel of Fig. 3 .18, each crystal element could be 
clearly identified even including the crystal elements located in the insensitive gap region. 
A crystal lookup table (see the middle panel of Fig. 3 .18) for the scintillator array was 
then generated using a special Kmax program. In a manner similar to the calibration of 
the 110 mm diameter circular detector described earlier in subsection 3.2.1, energy 
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calibration of individual scintillator pixels was carried out followed by correction of the 
non-uniformity of the detector in efficiency using a flood-correction table. This table was 
obtained with a planar, uniform liquid 1251 source ( ~ 40 !J.Ci) sufficient to cover the entire 
sensitive area of the detector. All the tables for detector calibration were implemented in 
the data acquisition program developed with Kmax software. The calibration was 
automatically executed by this program when acquiring data. The energy window for 
imaging in this work included photons with energy between 22 ke V and 40 ke V. 
Fig. 3.19. (Left) raw crystal map using ~15 !J.Ci 137Cs. (Central) crystal lookup table built 
upon the left image. (Right) a three-capillary image with uniformity corrected [1]. 
A three-capillary phantom was used to demonstrate the efficacy of the detector 
calibration. Each capillary contained about 10 !J.Ci Na125I in 11 em. As is evident in the 
right panel of Fig. 3.19, the planar image of the three-capillary phantom indicated neither 
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sensitivity loss nor visible deterioration of performance in the transition region between 
the two PSPMTs [1]. Shown in Fig. 3.20 is a profile image of the three capillaries. The 
similar peak values of the capillaries further suggested uniform sensitivity of the detector 
after calibration. 
Fig. 3.20. A profile image of the three capillaries suggesting uniform sensitivity of the 
detector after calibration. [ 1] 
3.3.1.3 Characterization - efficiency and resolution 
A capillary with 0.3 mm inner diameter loaded with 10 !lCi ofNa125I was used to 
determine the sensitivity of this compact gamma camera. The measured sensitivity was 
1840 cprnl!lCi with the capillary positioned about 4 mm from the surface of the 
collimator. 
For measurement of the spatial resolution of this detector, individual planar 
images were achieved with the capillary positioned at a variety of distances from the 
surface of the collimator, i.e., 4 mm, 17 mm, 32 mm, 47 mm and 62 mm. Three one-
pixel-width profiles of each image were obtained in top, bottom and gap region of the 
detector, respectively. After these profiles were fitted with Gaussian curves three full-
width-at-half-maximum (FWHM) spatial resolutions were then determined and averaged 
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to provide the spatial resolution of the detector at that distance. Presented in Fig. 3.21 is 
the mean spatial resolution (FWHM) of the compact detector as a function of the distance 
between the source and detector. A theoretical resolution curve determined by the 
formulae of Keller [62] and Smith et al. [63] is also presented in Fig. 3.21 in comparison 
with the experimental measurement. One may note the measured resolutions of this 
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Fig. 3.21 Theoretical prediction and experimental measurement of the resolution as a 
function of the distance between source and detector. [1] 
65 
Fig. 3.22 One-hour parallel-hole planar image of the lactating mouse injected with 10 j.lCi 
Na125I. The detector clearly delineates the accumulation of radioiodine in lactating 
mammary glands as expected. [1] 
3.3.1.4 Planar and SPECT imaging- animal studies 
In order to further verify the efficacy of this detector in biological studies, we 
have carried out animal studies including planar and SPECT imaging. The first study was 
planar imaging of a lactating mouse. Iodine is a significant element for a lactating mouse 
to produce milk in its mammary glands. Since iodine was transported into the mammary 
glands via the sodium iodide symporter (NIS), a well-known protein which is also 
expressed in other tissues such as thyroid glands and stomach [126], imaging of the 
lactating mouse injected with Na125I can delineate its lactating mammary glands 
expressing NIS. Presented in Fig. 3.22 is a 60-min gamma image obtained immediately 
after an anesthetized lactating mouse was injected with 10 j.lCi of Na125I. This image 
indicates the injection site in the left rear leg. As expected, high uptake of 125I is evident 
in the stomach region and thyroid and submaxillary glands. As in the salivary glands, 
individual lactating mammary glands of this mouse showed substantial accumulation of 
radioiodine and were clearly distinguished in the gamma image. In addition, the heart and 
lung region presented some level of accumulation of 125I owing to blood flow in 
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comparison with background tissues. The performance of the detector clearly 
demonstrated its utility in imaging 1251 -tagged ligands used in biological studies. 
Fig. 3.23. A transaxial image (left) and its surface plot (right) of the thyroid region of a 
mouse injected with 14 ~Ci Na125I. Both reconstructed images presenting dramatic 
difference in uptake of 1251 in the thyroid gland from in the submaxillary glands. [1] 
Experiments were also carried out in order to evaluate the performance of this 
detector for SPECT imaging. In the first test, a mouse was euthanized 65 minutes post 
injection of 14 11Ci Na125I. A SPECT scan of the mouse was accomplished with 3° 
intervals and 3 minutes for each of the 120 projections. Presented in Fig. 3.23 are a 
reconstructed image and its surface plot in the region containing both thyroid and 
submaxillary glands. The transaxial image clearly demonstrates the accumulation of 1251 
in the thyroid gland and the two submaxillary glands adjacent to the thyroid [1]. The 
surface plot of the same transaxial image further indicates the dramatic difference in 
uptake of 1251 in the thyroid gland from in the submaxillary glands. These results were 
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entirely consistent with what is expected for active iodine accumulation in these two 
structures [1]. 
The data from a second SPECT scan were obtained with another female mouse 
that bore a mammary tumor. The animal was euthanized 65 minutes after injection of 14 
).!Ci Na125I. Again, the 120 3-min projection images were taken with 3° spacing around 
the mouse. The reconstructed results are presented in Fig. 3.24 and Fig. 3.25. Shown in 
Fig. 3.24 are the reconstructed transaxial images of the mouse in the region containing 
the axillary mammary tumor, the thyroid and submaxillary glands [1]. As is evident from 
those images, NIS activity in this mammary tumor was substantial and higher than in the 
submaxillary glands but lower than the thyroid gland. The coronal views of the 
reconstructed results in Fig. 3.25 represent the distribution of radioiodine in the body 
region containing the thyroid, stomach and tumor. Those images also indicate the high 
level ofNIS activity in both the stomach and thyroid gland as expected. In addition to the 
clear NIS activity in the tumor, there was also clear accumulation of 1251 in the salivary 
glands [1]. 
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Fig. 3.24 Top image is a projection of a 
mouse bearing a mammary tumor at 0°, 
followed by five consecutive transaxial 
images (a-e, from tail to head) in the region 
containing both the thyroid and tumor. [1] 
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Fig. 3.25 Top image is a projection of a 
mouse bearing a mammary tumor at 
90°, followed by five consecutive 
coronal images (f-j, from ventral to 
dorsal side) ofthe entire mouse.[l] 
3.3.2 Development of the second "mouse-sized" gamma camera 
The results of the first compact gamma camera equipped with a 5 mm thick 
collimator (collimator #1) demonstrated the suitability of this detector for biological 
imaging of an entire mouse. However, it would be valuable to facilitate practical SPECT 
imaging of a mouse with such a detector using a shorter period such as 1 or 2 hours and a 
relatively low dose of radioisotope. One may also note from Fig. 3.20 that the resolution 
of this detector decreased substantially over a range of source-to-detector distance from 4 
mm to 4 7 mm. This range of distance is critical for SPECT imaging and the resolution 
degradation over this range may diminish the reconstructed resolution of SPECT. In 
order to achieve better resolution and to reduce imaging time, a second compact gamma 
camera containing a newly designed CuBe parallel-hole collimator has been built and 
installed on the gantry to form a dual-detector array with the newly designed parallel-hole 
collimator. 
The new CuBe collimator (Collimator #2) measures 6 mm thick with 0.3 x0.3 
mm
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openings and 0.05 mm septa. Collimator dimensions including its thickness, the 
hole size and septal thickness were determined based on the formulae of Keller [62] and 
Smith et al. [63]. The efficiency and spatial resolution of the new compact gamma 
camera were measured with a single capillary phantom with an inner diameter of 0.3 mm 
containing an activity of 10 !-LCi in 8 em length. The capillary phantom was imaged for 10 
min at distances of 4 mm, 17 mm, 32 mm, 47 mm and 62 mm from the detector. The 
spatial resolution was obtained from the average of a Gaussian fit to three different one-
pixel-wide slices across the line source. The theoretical resolution (Rs) was calculated 
based on the geometric resolution (Rg) of the collimator and the intrinsic resolution (Ri) 
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of the detector, i.e. R/ = R/ + R/. Spatial resolution of collimators #1 and #2 was 
compared based on this new detector. 
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Fig. 3 .26. Comparison of spatial resolution with the newly constructed detector equipped 
with 5 mm thick high-sensitivity collimator #1 and 6 mm thick high-resolution collimator 
#2 respectively. Relatively high resolution was preserved over a useful range with the 6 
mm thick collimator while the efficiency was lessened by a factor about 6 [119]. 
The measured efficiency of compact detector #2 is 1538 cpm/)lCi and 268 
cpm/f.!Ci at 4 mm away from the detector for 5 mm thick collimator #1 and 6 mm thick 
collimator #2 respectively. A plot is presented in Fig. 3.25 of measured detector spatial 
resolution (FWHM) vs. source-collimator separation. This result is in good general 
agreement with theoretical predictions fitted with an intrinsic resolution 2.8 mm which 
takes into account the 3 mm thick optical glass windows of the scintillation array, the 2 
mm thick PSPMT windows and an air gap of 3.2 mm between the collimator and 
scintillator. The difference between theoretical and experimental resolutions at a large 
distance from the detector for collimator #1 results from the 0.3 mm inner-diameter 
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capillary used for resolution measurement positioned at an angle with respect to the 
collimator having 0.55-mm square openings. As one may notice in Fig. 3.26, the 
advantage of collimator #2 is that it provides an acceptable resolution of 2.9 - 4.1 mm 
FWHM over a long range 4-47 mm of the distance between the object and the detector. 
This is significant for SPECT scans because such a range in distance typically exists 
when imaging mice. 
3.3.3 Conclusion 
We have developed novel compact gamma cameras particularly suitable for 
imaging an entire mouse either with planar scintigraphy or SPECT imaging. High 
performance has been demonstrated based on the evaluation of sensitivity, resolution and 
on preliminary animal studies. A collimator has been designed and manufactured in order 
to provide useful resolution with acceptable trade-off in sensitivity over a long range ( 4 -
47 mm) of source-to-detector distance, suggesting the potential for better results of 
SPECT imaging. In addition, the size of this detector makes it possible to employ an 
array of three or four such detectors simultaneously for short-period SPECT imaging of a 
mouse injected with a dose of radioactive ligands at a physiologically safe level. 
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Chapter 4 
Development of multi pinhole helical SPECT 
As mentioned earlier, pinhole collimation in SPECT has a definite advantage in 
achieving high spatial resolution, however, with a significant trade-off in sensitivity and 
sampling completeness. New multipinhole or helical SPECT imaging systems (see 
review in section 2.4) have been proposed to overcome the disadvantages of single-
pinhole SPECT in low-sensitivity and sampling completeness while keeping its 
advantage of high spatial resolution. In this work, we have sought to further enhance our 
imaging system by combining multipinhole circular SPECT with a helical orbit. Our 
principle goal has been to achieve enlarged FOV and enhanced resolution and sensitivity 
by taking advantage of that combination to facilitate high-quality imaging of specific 
organs such as the thyroid region of a mouse while retaining the potential of imaging the 
entire body. Shown in Fig. 4.1 is the current system incorporating multipinhole 
helical/circular SPECT in addition to parallel-hole SPECT. 
Described in this chapter are the system design, development, characterization 
comparison including field of view, sensitivity and resolution among various modes of 
pinhole circular or helical SPECT. Phantom studies were also carried out to validate the 
performance improvement. 
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Fig. 4.1. Photograph of the compact parallel-hole and pinhole circular/helical SPECT 
imaging system. Signal processing and storage instruments are not shown in this picture. 
All detectors are incorporated in a cylindrical gantry capable of rotating 360°. Detectors 
#1-2 are "mouse-sized" compact gamma cameras and detectors #3-4 are 110 mm 
diameter circular detectors. 
4.1 System design 
A 110 mm diameter circular detector (#4 in Fig. 4.1) was employed with pinhole 
collimation. Depending on the effective view area of the detectors and the requirements 
for acceptable spatial resolution, researchers have designed multipinhole collimation both 
with and without multiplexing of the image. The experimental results of Meikle et al. [65] 
indicate that the resolution of multipinhole circular SPECT achieved with multiplex 
effects is not appreciably different from that of single-pinhole SPECT. Therefore, we 
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have designed a collimator for multiplexed imaging based on the effective view area of 
this 110 mm diameter circular detector. 
To resolve the sampling incompleteness of single-pinhole SPECT resulting from a 
circular orbit and to enlarge the FOV of the detector, we have implemented a translation 
rack supporting the mouse bed along the axis of rotation (AOR) of the system so that a 
helical trajectory is employed. Such a combination of multipinhole and helical SPECT 
not only provides improved sampling completeness but also increases the field of view in 
both transaxial and longitudinal direction and hence enables large field-of-view imaging 
especially when a large magnification factor is involved. 
4.2 Gamma-ray detector for pinhole collimation 
The 11 0 mm diameter circular detector for pinhole imaging was described in 
section 3.2.1. A five-pinhole brass collimator as shown in Fig. 4.2 was employed for 
multi pinhole collimation. The collimator was 25 mm from the AOR of the gantry with a 
magnifying factor of 3 used in this work. 
12mm 




Fig. 4.2. Diagram of the 5-pinhole collimator. 
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4.3 Design of a five-pinhole collimator 
A typical pinhole collimator has the knife-edge shape as shown in Fig. 4.3a. For a 
knife-edge pinhole collimator, the analytic formulae of geometric sensitivity Ps, 
resolution Ra and effective diameter de have been previously expressed as equations (2.1-
2.3) in section 2.4.2. 
DcJ 
(a) (b) 
Fig. 4.3 (a) Knife-edge pinhole and the penetration effect; (b) Pinhole with channel edge 
As one may note, the effective diameter de actually takes into account the penetration 
effect at the edge of the pinhole. As indicated by the formula 2.3, the opening angle of the 
pinhole and linear absorption coefficient of the collimator material are the two factors 
affecting the effective diameter, which may degrade the resolution. To reduce the 
penetration effect at the edge of the pinhole, Smith eta!. employed a pinhole channel (see 
Fig. 4.3b) in design of a pinhole aperture instead ofthe usual knife edge [63]. 
The criteria for designing a multipinhole collimator have been proposed by Schramm 
et. al [66]. The projections from the multiple pinholes should be closely packed but with 
reduced multiplexing (especially multiple superposition) in order to take advantage of the 
effective detector area as much as possible and to minimize the uncertainty of the origin 
of a detected gamma ray. The object should also be sampled homogeneously with large 
incident angle avoided [ 66]. 
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The multipinhole collimator desired in our study serves the purpose of SPECT 
imaging of specific mouse tissues, particularly the thyroid, with the potential for whole 
mouse imaging. Therefore, the parameters of this multipinhole collimator have been 
determined accordingly based upon the formulae 2.1-2.3 in section 2.4.2 and criteria. 
Considering the effective detector area ( ~ 106 mm diameter sensitive region of the 
scintillator), a magnifying factor 3 was employed in order to achieve high-resolution 
(near 1 mm) imaging. This setting allows the detector to image a~ 35 mm diameter view 
area in the object plane containing the axis of rotation, which is sufficient to cover the 
mouse thyroid region. To achieve a good balance between resolution and sensitivity, the 
pinhole used in the collimator is 1 mm diameter. Since the geometric sensitivity also 
dramatically decreases with the increased distance between the object and collimator, the 
detector has to be placed as close as possible to the mouse, in this case, 25 mm. An 
opening angle of 90° was determined and employed for the pinhole. This acceptance 
angle is large enough for the detector to accept the incident photons from the effective 
view area in the objective plane. A channel edge was also employed for the pinhole to 
reduce penetration effects at the edge of the pinhole. The material used for the collimator 
is brass which has a linear attenuation coefficient about 60/cm for~ 35 keV photons from 
125!. A pinhole channel height of 0.2 mm can thus effectively reduce penetration effects at 
the edge region of the pinhole. 
Shown in the Fig. 4.2 is the diagram of a five-pinhole collimator chosen for imaging 
specific organs of small animals such as the mouse thyroid based on the sensitive area of 
the 110 mm diameter circular detector. The projection pattern of this multipinhole 
collimator was simulated using a 17.6xl2.8 mm2 rectangular object (see Fig. 4.4) whose 
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area is sufficient to cover the thyroid region of a mouse. Image multiplexing percentages 
were calculated based on this simulation. Multiplexing percentages are defined as the 
overlap area divided by the detector plane area. For the current five-pinhole collimator 
shown in Fig. 4.2, about 85% of the detector area is used to image the simulated object 
which includes a multiplexing area of ~ 20% of the detector area. The area of multiple 
superposition (an order of overlap more than 2) is less than 2%. 
Object (17.6 x 12.8 mm2) 
... 
Five-pinhole projection on the 
detector with an amplifying factor of 3 
Fig. 4.4. The simulated object (top) and projection (bottom) images using the five-
pinhole collimator with a magnifying factor of 3. 
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In summary, a five-pinhole collimator has been designed and fabricated. The 
actual collimator is shown in Fig. 4.5. Each pinhole in the 5 mm thick brass collimator is 
1 mm in diameter with an 0.2 mm (in height) pinhole channel and an opening angle of 
90°. A collimator of 1 to 4 pinholes can readily be effected by shielding the unused 
pinhole(s) with 0.5 mm lead sheet sufficient to block the 35 keV photons from 125!. This 
collimator has met our needs in multipinhole imaging studies. 
Fig. 4.5. Photograph of the five-pinhole collimator 
4.4 Step-and-shoot helical orbit 
A circular orbit for imaging was effected by a stepping motor (Fig. 4.6, Motor 1) 
which controlled rotation of the gantry around the axis of rotation. By adding a second 
SLO-SYN stepping motor (Fig. 4.6, Motor 2, 200 steps per revolution, Superior Electric 
Inc.) to control the displacement of the mouse bed along the AOR, a helical orbit was 
accomplished for step-and-shoot imaging. The second motor drove a steel rack, on one 
end of which the mouse bed was fixed, through a spur gear as seen in Fig. 4.6. This 
combination of the three components resulted in a stepping increment 1 mm per 1 0 steps 
along the AOR. 
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Fig. 4.6. Photograph of the setup to accomplish step-and-shoot helical orbit. Motor 1 
controls the rotation of the cylindrical gantry round the AOR. Motor 2 controls the 
displacement along the AOR ofthe rack with a mouse bed fixed to one end. 
4.5 Image reconstruction program and validation 
Image reconstruction programs were developed for multipinhole circular and 
helical SPECT based on an iterative ML-EM algorithm. The ML-EM algorithm was 
implemented using a method extended from that described by Li et al. [88] with Siddon's 
ray tracing technique [89] applied. No attenuation correction was applied. The image 
reconstruction programs were written in IDL language. Part of the program was adapted 
from Steven Meikle's image reconstruction program for pinhole circular SPECT. The 
reconstruction used cubic voxels with edge length 0.4 mm for pinhole collimation. In 
order to ensure that the image reconstruction programs work properly, they were 
validated by both simulation and phantom studies. 
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4.5.1 Simulation test 
As the core routine of image reconstruction is the same for pinhole circular or 
helical SPECT, it was sufficient to test the code using the simple case of single-pinhole 
circular SPECT. A set of projection images of a single capillary was simulated using a 
"perfectly" centered pinhole on the detector. To simplify the test, the simulated tube was 
positioned on the axis of rotation longitudinally. The projected tube in a pinhole image 
(Fig. 4.7a) is set to be uniform with a width of2 pixels (1.2 mm/pixel). The length of the 
tube is 38 pixels with detected activity 10 counts for each pixel. Because the geometric 
sensitivity for a pinhole is proportional to cos3cp (where cp is the incident angle of the 
photon) when this fine capillary is parallel to the axis of rotation, radioactivity in the 
actual digital tube should not be uniform. A total of 120 slices of such projection images 
was simulated with a magnifying factor of 3 used. Shown in Figs. 4.7b and 7c are 
transaxial and coronal images after image reconstruction with the programs. The 
transaxial image shows a reconstructed dot with a diameter of about 2 pixels (0.4 
mm/pixel). The coronal image indicates that the activity in both end regions of the digital 
tube is hotter than the central region. Both reconstructed images present exactly the 
results expected. 
Fig. 4.7. (a) simulated uniform projection of a digital tube; (b) transverse and (c) 
coronal images of the reconstructed non-uniform digital tube 
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To further verify that the program reconstructed the digital tube correctly, the 
longitudinal activity profile of the reconstructed tube was used to predict the activity 
profile of the tube in a pinhole projection image. The presumption is that if the program 
did the reconstruction properly, the predicted profile should be consistent with our initial 
simulation, in other words, that the longitudinal activity profile of the tube should present 
a plateau shape. Shown in Fig. 4.8 is a longitudinal profile of the activity in the 
reconstructed digital tube. Again, because the geometric sensitivity for a pinhole is 
proportional to col cp when the tube is parallel to the axis of rotation, the activity profile 
of the tube in a projection image can be predicted by multiplying the value at each pixel 
in Fig. 4.8 by a factor of col cp corresponding to that pixel. Shown in Fig. 4.9, the 
predicted profile is flat and consistent with the uniform projection of the tube as initially 
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Fig. 4.9 Predicted profile in a projection image of the reconstructed digital tube using the 
values in Fig. 4.8. This predicted profile is consistent with the uniform projection as 
initially simulated. 
4.5.2 Phantom tests 
The image reconstruction program of Steve Meikle is accompanied by a sample 
set of projection images from a single-pinhole circular SPECT scan of a five-capillary 
phantom. The 18 projection images in the data set were obtained at angular positions 
separated by 20° increments. Each projection image is 64 x 64 pixels, in which the 
effective area of the detector takes 4 7 x 4 7 pixels. A magnifying factor of 2 was 
employed for this phantom test with 45 mm between the axis of rotation and the pinhole 
collimator. The single pinhole is located at the center with respect to the detector. The 
results after image reconstruction using my program are compared with those of Meikle's 
program as a standard. Compared are both reconstructed images and the total counts in 
the reconstructed volume after each iteration. The reconstructed images from both 
programs are presented in Fig. 4.1 0. As one may note, these two reconstructed images are 
almost identical and consistent in detail. 
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Fig. 4.10. Reconstructed images after five iterations using Meikle's program (left) 
and my program (right), respectively. 
Listed in Table 4.1 are the total counts in the reconstructed volume after each 
iteration (up to five iterations in this comparison). The results show that the total counts 
and their trend with the iteration number are consistent within errors using both image 
reconstruction programs. 
Iteration number Steven Meikle' Program My Program 
1 84872 81035 
2 83622 80077 
3 83165 79860 
4 83122 79860 
5 83307 79957 
Table 4.1. Total counts in the reconstructed images 
A further quantification test of the image reconstruction program for multi pinhole 
helical SPECT was carried out with a phantom containing three 1251 sources simulating 
the thyroid region of a mouse. Details can be found in section 5.2.3.3. Briefly, using 
image analysis programs, we compared the ratio among the region of interests (ROis) of 
the three sources in a planar gamma-ray image with the ratio based on the reconstructed 
results of a two-pinhole helical SPECT scan of the phantom. Excellent agreement has 
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been achieved between those two ratios, which further trends to verify the efficacy of the 
image reconstruction program I developed. 
4.6 SPECT scans 
Unless stated otherwise, every SPECT run in the following set of experiments 
was taken in 3° increments and with a 3 minute dwell time at each angular position for a 
total of 120 projections. The step increment along the axis of rotation is 0.5 mm for the 
helical orbit. A magnifying factor of 3 was used in each scan with the radius of rotation 
for SPECT imaging set to 2.5 em. The energy window set for gamma-ray imaging was 
from 22 to 40 ke V, which was suitable for the photons emitted from 125I. 
4.7 Characterization comparison 
Characterization comparison was carried out among single-, three-, and five-
pinhole circular and helical SPECT. The central pinhole and the three pinholes on the 
diagonal of the five-pinhole collimator were employed respectively for single- and three-
pinhole collimations by shielding the unused pinholes. 
4.7.1 Field ofview 
In order to simplify the comparison of FOV for the multipinhole case, we 
compared the effective view area (EVA) in the plane passing through the AOR. The FOV 
of the corresponding collimation is simply the volume by rotation of the EVA around the 
AOR. The EVA of pinhole collimation was calculated based on the geometry of the 
pinholes with a magnifying factor of 3. The EV As of three- and five-pinhole collimation 
were compared with single-pinhole collimation as reference. A 17.6xl2.8 mm2 
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rectangular object big enough to cover the thyroid region of a mouse was simulated to 
calculate the multiplexing percentage which is the overlap area divided by the overall 
area of detector plane. 
Collimator Single-pinhole 
Effective 


































Table 4.2. Characterization comparison among various modes of SPECT. One may note 
view area increase is over the single-pinhole case. Multiplexing percentage is the overlap 
area divided by total detector area with a simulated 17.6xl2.8 mm2 rectangular object 
whose area is large enough to cover the thyroid region of a mouse. 
As shown in Table 4.2, EV As of three- and five-pinhole collimation have been 
enlarged by 81% and 138% respectively compared to single-pinhole collimation. For a 
conventional circular orbit, however, one may readily show that the overall FOV is the 
same for both three- and five-pinhole case. The FOV of the helical mode is extended 
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from its corresponding circular mode which eventually depends on the displacement of 
the detector along the AOR. By choosing a suitable step increment along the AOR, one 
expects the FOV of a helical mode to cover a specific region of interest or the entire body 
of the animal. 
The enlarged EVA of multi pinhole collimation indicates increased sampling area 
and efficiency for a single projection of the object. However, the five-pinhole collimation 
causes multiple-fold (up to 5-fold) multiplexing though it has about the same total 
multiplexing percentage as the three-pinhole collimation. Such a high-fold multiplexing 
image results in more uncertainty in photon origin and may affect the reconstructed 
resolution adversely. 
4. 7.2 Efficiency 
The efficiency of different modes of SPECT/HSPECT was determined by a 
phantom simulating the thyroid region of a mouse. The phantom measures 15.9 x 15.9 x 
15.9 mm3 and contains three small voids. Each small void holds a hot source. Small 
pellets fitting exactly in the void served as isotope media after being immersed in 
radioisotope solution for homogeneous accumulation of the isotope 125!. The pellets were 
taken out after a few days, allowed to dry naturally in a safety hood and then firmly 
sealed in the void. Such a method minimizes possible radioactive leakage. The bottom 
two voids were separated by 3 mm representing the salivary glands of a mouse while the 
top one simulating the thyroid is spaced 2 mm away from them. The thyroid phantom 
contains a total of 15 JlCi with 5 JlCi at each void. For each mode of SPECT/HSPECT, 
the phantom was imaged at 120 positions with 3° increment and 3 min at each position. 
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The step increment of helical SPECT along the AOR is 0.1 mm with a total of 12 mm 
displacement for the entire imaging. The total counts of all the 120 planar images were 
then collected and averaged over time to obtain the efficiency. 
As expected, the efficiency of pinhole circular SPECT is almost identical to that 
of short-range helical SPECT. Moreover, the efficiency of five-pinhole collimation is 
increased significantly to the level near that of parallel-hole collimation with the 5 mm 
thick high-sensitivity collimator #1, i.e. 1538 cpm/f.lCi, while the single-pinhole 
collimation shows relatively poor sensitivity. 
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Fig. 4.11 Reconstruction resolution (FWHM) as a function of ML-EM iteration number 
for various modes of pinhole circular or helical SPECT 
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4.7.3 Resolution 
Test scans of different modes of pinhole SPECT/HSPECT were carried out using 
the three-capillary phantom shown in Fig. 4.13(a). One of the capillaries was located 5.6 
mm off the AOR and used to determine the reconstruction resolution (FWHM) of each 
mode of pinhole circular or helical SPECT. Each FWHM was obtained through Gaussian 
fit. The step increment along the AOR was 0.5 mm for each 3° rotation of helical SPECT. 
Five transaxial images were reconstructed at different positions of the capillary for each 
scan. The intensity profiles along the line across the center of the reconstructed capillary 
region were then analyzed and fitted to Gaussian curves. Each FWHM was then 
calculated and the group corresponding to each SPECT mode was averaged to obtain the 
resolution of the mode. The relationship was determined between the reconstruction 
resolution and iteration number. 
Presented in Fig. 4.11 is the plot of the overall reconstruction resolution as a 
function of ML-EM iteration number for various modes of pinhole circular/helical 
SPECT. Six sample profiles of the capillary in the transverse reconstructed slices after 13 
iterations are presented in Fig. 4.12 corresponding to 1-, 3- 5-pinhole circular/helical 
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Fig. 4.12. Six profiles (a)- (f) ofthe capillary in the transverse reconstructed slices after 
13 iterations for 1-, 3- 5-pinhole helical SPECT (a, c, e) and circular SPECT (b, d, f) 
90 
4.8 SPECT imaging - phantom studies 
We have made preliminary performance evaluations based on phantom studies. 
An experiment was carried out to demonstrate the extended field of view. Shown in 
Figure 13(a) is the phantom set up with three capillary tubes, each of which was 0.3 mm 
in inner diameter and contained 18 1-1Ci N a 1251 in 8 em length. One capillary was put on 
the intersecting line of two perpendicular planes. A second capillary in one of the planes 
reconstructed slices separated by 43 mm 
a 
Fig. 4.13. A 54 J..!Ci three-capillary phantom study of 3-pinhole helical SPECT. (a) 
Phantom setup. (b) A 3-min projection (c) Reconstructed slice 1 (d) Reconstructed slice 2. 
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was parallel to it with 8.6 mm separation and a third one was in the other plane at an 
angle of 6.6°. A 3-pinhole collimator was employed and helical SPECT was performed 
with an object translation step increment of 0.5 mm (the total movement along the AOR 
was 60 mm). Shown in Fig. 4.13(b) is a typical 3-min projection of the phantom. Two 
transverse reconstructed slices are presented in figures 13(c)-(d). They were taken at 
positions separated by about 43 mm, which was larger than the 35 mm diameter of the 
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Fig. 4.14. (a) A transaxial view of the phantom made with 6 capillary tubes placed side 
by side. Each tube contained ~10 f.!.Ci Na125I in 8 em length. (b) A transaxial image of a 
3-pinhole helical SPECT scan of the phantom. The step increment along AOR is 0.5 mm. 
(c) The profile ofthe six capillaries in the reconstructed image (b). 
To demonstrate that the calculated reconstruction resolution is reasonable, we did 
three-pinhole helical SPECT of the capillary phantom shown in Figure 14(a), which was 
made with six glass capillary tubes placed side by side. The helical increment along the 
AOR was 0.5 mm per step. Each capillary contained~ 10 f.I.Ci Na125I in 8 em length. The 
diameter of each capillary was identical to that used for resolution measurement, namely, 
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0.3 mm in inner diameter and 1.45 mm in outer diameter. Therefore, the center-to-center 
distance of two adjacent tubes was 1.45 mm. The phantom of six capillaries placed side 
by side is shown in Fig. 4.14(a), followed by the reconstructed image presented in Fig. 
4.14(b ). Shown in Fig. 4.14( c) is the profile of the capillaries in the reconstructed image 
of a 3-pinhole helical SPECT scan. Each capillary can be resolved consistent with the 
calculated resolution. 
Performance of the imaging system was further evaluated using an ultra-micro hot 
spot phantom (Data Spectrum Co.) filled with ~270 1-1Ci Na125I, which had a radioactivity 
concentration of 54 J..1Cilml. The phantom is 3.50 em in outer diameter and about 5.5 em 
in height. The rod insert is 2.7 em in diameter with a height of 0.99 em. The hot rod 
diameters of the six wedge-shaped regions in the insert are 0.75, 1.0, 1.35, 1.7, 2.0, and 
2.4 mm, respectively. The center-to-center spacing of the rods in each wedge is two times 
the rod diameter. An additional ~ 1.3 em thick plastic disk insert was used to reduce the 
total volume of solution required to fill the phantom. Helical SPECT scans using this hot-
rod phantom were carried out with one or three pinholes with planar projections at 3 ° 
increments and 3 min/projection. The step increment was set to 0.1 mm considering the 
thickness ( ~ 10 mm) of the rod insert. Out of the 120 projections obtained in each scan, 
sixty projections with angular positions at 6° intervals were used to represent a three-hour 
helical SPECT scan with a step increment of 0.2 mm along the AOR. Images were 
reconstructed using 30 and 60 iterations for 1- and 3-pinhole helical SPECT, respectively. 






Fig. 4.15. (a) A transaxial view of the hot-rod phantom using single-pinhole helical 
SPECT with 3 ° angular increments and 0.1 mm step increments along the AOR. Each of 
the 120 projections was 3 min/projection. The hot-rod phantom contained 270 ~Ci 125I 
with a concentration of 54 ~Cilml. The hot rod diameters of the six wedge-shaped 
regions in the phantom are 0.75, 1.0, 1.35, 1.7, 2.0, and 2.4 mm, respectively. (b) An 
image reconstructed from 60 slices out of those 120 projections to represent three-hour 
1pHSPECT (c) One 3-min projection of the hot-rod phantom of a three-pinhole helical 
SPECT scan with the same imaging parameters as the 1 pHSPECT scan. (d) A transverse 
image reconstructed from the 120 projections of the 3pHSPECT scan. 
The reconstructed images of the hot-rod phantom are shown in Fig. 4.15 for 
single- and three-pinhole helical SPECT (1pHSPECT or 3pHSPECT). The image from 
six-hour 1 pHSPECT can resolve the 1 mm diameter rods well and a few of the 0. 75 mm 
rods. The image reconstructed from 60 out of the 120 projections of the six-hour 
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1 pHSPECT scan reflects some noise owing to reduced statistics but still resolves the 1 
mmrods. 
Similarly, as shown in Fig. 4.15(d), the reconstructed image of six-hour 
3pHSPECT can also resolve 1 mm rods well and some of the 0.75 mm rods. The enlarged 
field of view using three pinholes facilitates reconstruction of the circular gap region in 
the phantom between the rod insert disk and the inner wall of the container. This hot 
circular region is only partially shown in single-pinhole cases. Some artifacts appear in 
the 3-pinhole cases mainly owing to the fact that there are always parts of the phantom 
truncated in projections through each pinhole as evidenced by a three-pinhole projection, 
Fig. 4.15( c). This results from the relatively large scale of the phantom contrasting 
somewhat with the main focus of the system design on imaging small organs of a mouse 
such as the thyroid with a magnifying factor 3. Multiplexing effects can be another factor 
contributing to artifacts. Results of both the single- and three-pinhole helical SPECT 
clearly demonstrate that the resolution we measured based upon fine capillaries 
containing high radioactivity concentration are also valid for a more conventional case in 
which a radioactivity concentration of a few J.!Ci/ml of radioactivity is used in the hot rod 
phantom. 
4.9 Discussion and conclusion 
We have described the development of a compact gamma-ray imaging system 
incorporating multipinhole helical/circular SPECT in addition to parallel-hole SPECT. 
The characterization of various modes of pinhole SPECT has been investigated using 
radioactive phantoms. As shown in Table 4.2, the diameter of the FOV of 3- or 5-pinhole 
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circular SPECT is increased by a factor of ~ 1.5 compared with the single-pinhole case. 
The FOV is further increased in the longitudinal direction for multipinhole helical 
SPECT depending on the step increment along the AOR. 
The resolution comparison among pinhole SPECT/HSPECT shows that a 
reconstructed spatial resolution of 1.2 - 1.5 mm can be achieved with this system. Both 
the profiles in Fig. 4.12 and the result of 3-pinhole helical SPECT of the six-capillary 
phantom in Fig. 4.14 demonstrate that the calculated FWHM resolution is reasonable. 
The results in Fig. 4.11 indicate that there is no appreciable difference in the 
reconstruction resolution among one-, three- and five-pinhole SPECT using both circular 
and helical orbits. Referring to Table 4.2, the results further indicate that acceptable 
reconstruction resolution can be achieved with this system while the efficiency is 
enhanced substantially with an increase in the number of pinholes from one to five. On 
the other hand, we observed slower convergence of the ML-EM algorithm for multiple 
pinhole data than for a single pinhole in either the circular or helical case. There is also 
slight loss of reconstruction resolution with increasing iteration number. Both these 
results are consistent with the report of Meikle et al., whose simulation result of mean 
squared error versus iteration number indicated both slower convergence of the ML-EM 
algorithm for multipinhole SPECT and increased noise with increasing number of 
iterations [65]. 
The measured resolutions are further demonstrated by experiments using hot-rod 
phantoms. Results from both single- and 3-pinhole helical SPECT can resolve hot rods as 
small as 1 mm in diameter. The reconstructed images of the 3-pinhole case show some 
artifacts in that phantom as explained above. Small organs in the mouse, such as the 
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thyroid, can be fully projected on the detector through two or more pinholes 
simultaneously with little or no multiplexing area, which can substantially improve the 
image quality. The system design is also intended for a relatively low injection dose of 
radioactivity in biological studies. The results here demonstrate that our system has the 
potential for high-resolution SPECT imaging using a radioactivity concentration as small 
as 54 llCi/ml, which is of the same order as in the thyroid of a mouse injected with tens 
of J..lCi of 125!. 
Our system is constructed in an economical, compact and, especially, expandable 
manner. An additional small fluoroscopic X-ray apparatus (Lixi, Inc.) installed on the 
gantry is available to provide dual-modality imaging [117] as described in section 3.1. 
More "mouse-sized" parallel-hole detectors may be incorporated to facilitate faster three-
or four-head SPECT of a small animal. The pixellated Nal scintillators for both parallel-
hole and pinhole detector are 5 mm in depth, which is adequate for imaging various 
higher energy isotopes such as 99mTc if a suitable collimator is implemented. 
In conclusion, a compact SPECT system has been built and tested incorporating 
multipinhole helical/circular SPECT in addition to parallel-hole SPECT. The variety of 
imaging modes in this system can readily meet the requirements for a range of small 
animal applications. Our phantom studies have demonstrated the feasibility of employing 
multipinhole helical SPECT for small animal imaging. The results indicate that the 
resolution of our system is virtually identical for one, three and five-pinhole SPECT, 
while the efficiency is enhanced by the presence of the additional pinholes. The 
accomplishment of enlarged field of view, very good resolution and improved sensitivity 
with multipinhole circular or helical SPECT suggests the potential for high-resolution 
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imaging of small tissues or entire animals with good sensitivity. Additional work is 
planned with realistic animal phantoms, followed by studies with anesthetized mice. 
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Chapter 5 
In vivo gamma imaging in studies of the mouse thyroid 
Among mouse tissues and organs of interest to investigators, the thyroid is 
particularly useful for imaging studies in biological research as either target tissue or a 
system for proof-of-concept tests. Radionuclide imaging of the thyroid is practicable 
considering the underlying molecular biology of the expression of the sodium iodide 
symporter (NIS), an intrinsic membrane protein facilitating transport of active iodide into 
the thyroid gland. The thyroid is thus particularly suitable for such imaging given that 
NIS-expressing follicular cells take up several radioisotopes, for example, 125!, 99mTc and 
188Re [127]. The thyroid has a relationship to a number of diseases and thyroid imaging 
has potential implications for pathophysiology and therapeutics in those diseases m 
addition to providing a better understanding of thyroid physiology [128, 129]. 
This chapter describes the application and potential of our imaging system in 
thyroid studies. The first section of this chapter briefly describes the application of planar 
gamma imaging in re-evaluation of the use of KI in blocking the uptake of radioiodine in 
the thyroid of living mice. In this discussion the emphasis is on gamma imaging and 
results rather than biological investigation. The remainder of this chapter presents in 
detail the in vivo study of visualizing NIS in the mouse thyroid using the multipinhole 
helical SPECT system (see detail in Chapter 4) with a relatively low dose of 1251. 
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Complementary results from molecular biology assays including immunohistochemistry 
and reverse transcriptase polymerase chain reaction are also presented to verify that 
radioiodine incorporation in the thyroid gland reflects NIS expression, validating the 
SPECT imaging of the mouse thyroid at the molecular level. 
5.1 In vivo study of KI blocking efficiency in mice 
As mentioned previously, low emission energy and the reasonably long half-life 
of 125I make it an efficient tool for imaging a small animal over more extended periods of 
time. However, radioiodine administered into the mouse body usually is transported into 
the thyroid and "trapped" there in the form of thyroid hormones. This can prolong thyroid 
exposure to radiation and could eventually result in thyroid malfunction [2]. To protect 
the mouse thyroid from such potential damage in biological studies, we orally 
administered potassium iodide in order to block the thyroid from taking up radioiodine in 
these studies. Initially we employed the FDA-recommended human blockade dose of KI 
scaled to the body weight of the subject mice. However, we found that the blockade 
efficacy was incomplete. It is worth noting that hundreds of radio-iodinated compounds 
are widely used in biomedicine both with animal and human subjects. In addition, there 
can be a need to protect humans from the potential accidental release of radioiodine 
fission fragments, especially 1311 and 1291 associated with nuclear power [2]. Therefore, 
we have recently carried out a study to re-evaluate KI -blocking efficiency in both thyroid 
and extrathyroidal tissues including stomach, thorax, and leg using the mouse model and 
our imaging system. 
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To achieve these mms, we have designed a set of experiments for the re-
evaluation of Kl blocking efficacy and applied in vivo gamma imaging using a 110 mm 
diameter circular detector and image analysis into these experiments. My principle 
contribution in this work was to carry out data acquisition of gamma imaging and image 
processing required by the designed experiments, to determine the relationship between 
whole body clearance and KI dose administered into the mice, and to provide support for 
data analysis including improving ROI programs written in IDL. 
5.1.1 Gamma-ray detector and imaging 
The detector employed in this study has been described in detail in previous 
publications [68, 117] and also briefly in Section 3.3.1. To confirm the accuracy of 
gamma-ray imaging using this detector and its applicability as a tool for in vivo biological 
studies, we compared the ROI data of a mouse thyroid obtained from gamma images with 
the counts of the alternative method, i.e. liquid scintiallation (LS) counting of the 
dissected thyroid tissue[2]. A significant correlation (r2 = 0.9842, p < 0.05) was found 
between the results of these two independent methods, which validate the efficacy of this 
gamma camera for imaging application in biological studies. 
Planar gamma imaging of the mice was carried out in vivo in this study. Each 
anesthetized mouse was imaged immediately after a dose of ~14 f.!Ci Na125I was 
administered into the mouse body. The data from one full-hour imaging of each mouse 
included information on each individual gamma-ray count, its spatial position and time, 
were collected using a Macintosh G3 computer. The mouse was kept anesthetized and 
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alive during the imaging period. After data collection, the data files were transferred to a 
Macintosh G4 computer for data analysis. 
5.1.2 Data analysis 
Using computer programs written in IDL language (ITT Corporation), the data 
files were grouped into several 5-min interval blocks. Each block is stored in a file (called 
a "timecut") representing the two-dimensional distribution of radioiodine in the mouse 
body accumulated in the corresponding five-minute interval. Therefore, the set of 
timecuts can "re-display" the 2D distribution of radioiodine and its change in the mouse 
body over the full-hour imaging period. By placing a region of interest on an image and 
collecting the total counts, one can quantitatively evaluate the level of cumulative 
radioiodine in target tissues such as the thyroid in vivo and its change over time. The ROI 
size used for analysis of the mouse thyroid gland has been set to 4 x 4 pixels (1.2 x 1.2 
mm2 per pixel). In addition, ROis with a size of 8 x 8 pixels were used for analyzing 
other tissues including thorax, stomach, left leg and injection site. For easy comparison 
among those tissues, all the ROI results were normalized as the percentage of the total 
injection dose (%ID) determined by the total counts of the whole-mouse ROI with a size 
of 30 x 80 pixels. 
5.1.3 Experiments and results 
In this subsection, the purposes and results of the experiments designed to 
evaluate the blocking efficiency of Kl in the thyroid and extrathyroidal tissues are 
described. Those results have been published recently in Health Physics [2]. The figures 
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presented in this subsection except Fig. 5.5 and Fig. 5.6 are reproduced from that 
publication with permission granted by the publisher Lippincott Williams & Wilkins. 
These experiments studied the dynamic change of the radioiodine accumulated in 
the target tissues at different time periods (0 to 1 hour, 1 hour to 24 hours, 1 hour to 7 
days, respectively) after injection of Na125I into the mouse body. A variety of KI 
blockade dosage employed, no KI, IX, 3X, 5X and lOX KI doses, where IX was 
equivalent to the dose scaled from human dose to mouse by body weight. The dynamic 
change of radioiodine level during the first hour after injection was compared among the 
thyroid, stomach and injection site with thorax and left leg as references for background 
(see Fig. 5.1). The KI blocking dose was fed to the mouse orally 60 minutes prior to 
injection of the radioiodine. The results in Fig. 5.1 indicate that, although a IX KI dose 
effectively blocks the radioiodine accumulation in the thyroid, a higher KI dose such as 
5X or 1 OX can substantially increase the blocking efficiency when administered prior to 
exposure to radioactive iodine [2]. As to other tissues, the KI blocking effects are similar 
for the different KI doses. Presented in Fig. 5.2 is a set of five images of mice 
administered a variety ofKI blocking dose prior to injection of radioiodine. These images, 
taken in the time period 50-55 minutes after injection of radioactive iodine, show mice 
administered blocking doses of 0, 1, 3, 5 and lOX the scaled human KI dose prior to 
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Fig. 5.I. The dynamic change of radioiodine uptake during the first hour after injection in 
thyroid, stomach, injection site, thorax and left leg. A variety of KI blockade dosage was 
employed including no KI, IX, 3X, 5X and I OX KI doses, where IX was equivalent to 
the dose scaled from human dosage to mouse based on body weight [2]. 
Fig. 5.2. Images which reflect KI blocking effects in different target tissues for five mice 
receiving KI blocking doses of 0, IX, 3X, 5X, I OX the scaled human blocking dose. The 
images were taken during the period 50-55 minutes after injection of radioactive iodine 
[2]. The KI doses were administered orally 60 minutes prior to 125! injection. 
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For comparison to the evaluation of immediate blocking efficiency in Experiment 
I, a second experiment was carried out to examine the retention of the KI blocking over a 
longer time period at I hour, I day and 7 days following exposure to radioiodine. In this 
experiment, IX and 5X ~I human doses were used with unblocked mice as control 
animals. Consistent with Experiment I, the results presented in Fig. 5.3 show 5X KI 
human dose, administered 60 minutes before injection of 125I, continues to provide a 
higher level of protection than the IX KI dose 7 days after radioiodine injection [2]. 
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Fig. 5.3. Evaluation of the retention of the IX and 5X KI blocking efficiency at times I 
hour, I day and 7 days following blocking dose and exposure to radioiodine with 
unblocked mice as control animals [2]. 
A third experiment was designed to learn whether the significant drop in activity 
between I hour and I day as shown in Fig. 5.3 happened in a precipitous or a more 
gradual manner. This experiment examined the 1251 retention in thyroid, stomach and 
thorax at I, 6, I2 and 24 hours after administration of the blocking dose followed 60 
minutes later by injection of the 125I dose. The blockade dose administered to mice was 
IX KI human dose [2]. The results in Fig. 5.4 indicate that thyroid radioiodine content 
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declined gradually over the first 24 hours after injection while, surprisingly, the 








Fig. 5.4. Evaluation of 125I retention in thyroid, stomach and thorax at 1, 6, 12 and 24 
hours after injection using 1X Kl human dose which was administered orally 60 minutes 
prior to 125I injection [2]. 
In an attempt to determine the relationship between urine or whole body clearance 
and KI dose, we carried out Experiment IV using a small sample of mice (n = 2 for each 
group orally administered OX, 1X and 5X human KI dose, respectively). Again, KI dose 
was administered 60 minutes prior to radioiodine injection. After injection, each mouse 
was put back in an individual cage, inside which there was an absorbent paper entirely 
covering the bottom area of that cage in order to collect the urine and feces of that mouse. 
Twenty four hours following radioiodine injection, each mouse was in vivo imaged for 5 
minutes and the image was saved as a timecut. The mouse was then sacrificed 
immediately after imaging. The feces, the paper containing mouse urine and the mouse 
body were collected and imaged separately followed by data analysis. For normalization 
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Fig. 5.5 Urinary clearance as a function of equivalent human KI dose 24 hours after 
radioiodine injection. A variety of KI doses (OX, IX and 5X) was orally administered 
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Fig. 5.6 Whole body clearance as a function of equivalent human KI dose 24 hours after 
radioiodine injection. A variety of KI doses (OX, IX and 5X) was orally administered 
into the mouse 25 hours prior to gamma imaging. 
injection dose in this case. My analysis showed that over 96% of radioiodine in the 
mouse body had been cleared through urine and feces during the first 24 hours after 
injection (see Fig. 5.6). Both urinary clearance (see Fig. 5.5) and whole body clearance 
(see Fig. 5.6) for blocked animals were substantially higher than unblocked animals 24 
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hours after radioiodine injection, which was consistent with our previous results. The data 
also indicated no statistically significant differences between either urinary or whole 
body clearance using IX and 5X human KI doses. 
5.1.4 Discussion and conclusion 
The results of this study re-evaluating the blocking efficiency of KI suggest that 
the KI human dose equivalent provides much less effective protection for the mouse 
thyroid than a higher KI dose. The dose effects are also interesting in extrathyroidal 
tissues, in particular the stomach, and could be important for those tissues-related studies. 
In particular, this study demonstrated the utility and advantages of our imaging system as 
a promising tool in a range of similar biological studies. 
This system allows in vivo gamma imaging of the mice. This significant feature 
facilitates evaluation of the KI-blocking effects on the same animal repetitively over a 
chosen time period. A small number of mice was required in this study as a consequence. 
The real-time feature of the imaging system makes it possible for us to examine the 
distribution of radioiodine content in target tissues in both dynamic and static manners. 
Moreover, owing to the relatively high spatial resolution ( ~ 2 mm), good sensitivity and a 
field-of-view sufficient for whole-mouse imaging, we are able to obtain high-quality 
gamma images using a relatively low dose of radioiodine ( ~ 14 ~-tCi). Those gamma 
images enable us to distinguish the target tissues easily with good detail. Hence, more 
accurate ROI analysis can be carried out as well as comparison among either different 
mice or different tissues in the same mouse. In particular, statistical variation in the study 
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arising from the inter-animal differences is reduced since each animal could serve as its 
own control. 
In conclusion, this study, based on a mouse model, suggests the potential value of 
reconsidering KI dosage or alternative thyroid blockade pharmaceuticals for emergency 
I 
protection of human thyroid [2]. On the other hand, since mice have been extensively 
used in preclinical research to study tumor therapy through radioiodine uptake, this study 
may also prove of value in determining the effective and appropriate dosages for mouse 
thyroid protection. 
5.2 In vivo multipinhole helical SPECT imaging of a mouse thyroid 
The study described in Section 5.1 suggested the need for further evaluation ofKI 
blocking efficiency while simultaneously indicating the need of novel, non-invasive 
technologies for further addressing this health issue [2]. Such in vivo study on the mouse 
thyroid may also benefit from higher resolution that can yield data on the three-
dimensional biodistribution of the thyroid's saturation. This information can be provided 
by data obtained through SPECT techniques. Several clinical studies have demonstrated 
the advantages of SPECT in effectively detecting thyroid carcinoma, evaluating tracheal 
compression, finding the extension of multinodular goiter and determining the thyroid 
volume and mass for dosimetry of radioiodine therapy [130-133]. However, the 
requirements of both high resolution and sensitivity and the difficulty in localizing 
radiotracers have limited the utility of SPECT in work with small organs such as brain or 
thyroid using mouse models [134, 135]. 
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This situation has been improved by a SPECT system incorporating high-
performance detectors and/or high-resolution pinhole collimation [1, Ill, 116, 136]. As 
demonstrated in section 3.3.1.4, ex vivo parallel-hole SPECT based on a compact gamma 
camera illustrated considerable difference between the uptake of 1251 in the thyroid region 
and in the salivary glands. The first successful in vivo 1251 SPECT image was achieved by 
McElroy et al. [136] using a single-pinhole A-SPECT system and 1 mCi Na1251, and 
clearly delineated both lobes of the thyroid in the reconstructed image. Using a 100 1-1m 
diameter gold alloy pinhole constructed by electron discharge machining, Beekman et al. 
successfully achieved a spatial resolution of 200 1-1m for planar imaging of the thyroid of 
a mouse injected with 250 J.!Ci Na1251 [116]. That work suggested the potential for ultra-
high-resolution SPECT of small organs such as the mouse thyroid. Hong et al. reported 
the ex vivo 1251 imaging of the thyroid of a rat using a compact SPECT/CT system and 1 
mCi to localize the isotope [111]. 
The major drawback of high-resolution single-pinhole SPECT is low sensitivity 
[137]. A high dose can compensate for the low sensitivity of single-pinhole SPECT. That 
dose, however, may be a factor affecting physiology and leading to invalid results [138]. 
The use of large amounts of radio tracer brings the potential for pharmacologic effect risk 
and increases radiation burden which can cause tissue damage [139]. The high dose may 
further change the result of imaging studies repeated over time and prevent longitudinal 
studies using the same animal [139, 140]. Cao et al. reported that a dose below 1 mCi is 
suggested for mouse studies using 99mTc-tagged ligands based upon preliminary 
unpublished dosimetry data [137]. The high-dose effect in thyroid imaging using 
radioiodine is a significant issue needing consideration. After being administered into the 
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body, the radioiodine transported into the thyroid is incorporated into the hormones 
triiodothyronine and thyroxine. This prolongs thyroid exposure to radiation and could 
eventually result in thyroid malfunction [2]. Low emission energy (~35keV) and the 
reasonably long half-life (59.4 days) of 125I make it a useful tool for imaging a small 
animal over more extended periods of time, which, however, also requires the applicable 
dose be kept as small as possible. 
As the review in Chapter 2 indicates, recent advances of pinhole SPECT have 
provided a potential path to solve these issues with regard to both resolution and 
sensitivity of mouse thyroid imaging. In Chapter 4, I have described the details of 
development and phantom tests of multipinhole circular/helical SPECT. Herein we 
demonstrate the applicability of multi pinhole helical SPECT to in vivo molecular imaging 
by presenting results of a study of visualizing NIS activity in the mouse thyroid. This 
work has employed a low-level dose of 125! ranging as small as 12 !J.Ci for phantoms to 
130-200 !J.Ci for subject mice in SPECT imaging. This is significantly lower than the 
order of millicuries used in previously reported 1251 SPECT imaging of mouse thyroid 
[111, 136]. In addition, we verify that multi pinhole helical SPECT is a valid tool for 
monitoring biological activity at the molecular level such as NIS expression in the 
thyroid through molecular biology assays. Collaborators Eric Blue and Stephen Schworer 
of Biology have carried out immunohistochemistry and RT-PCR, respectively. 
Correlative results from both imaging and molecular assays can thus validate 
multi pinhole helical SPECT for in vivo molecular imaging of biological processes. 
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5.2.1 Multipinhole helical SPECT system and scans 
The multipinhole helical SPECT system has been described in detail in Chapter 4 
and will be briefly mentioned here. In this work, two pinholes (the central and lower left 
pinholes) are used with no overlapping area of the projections of the mouse thyroid from 
both pinholes. Other unused pinholes were shielded with 0.5 mm lead sheet sufficient to 
block~ 35keV photons from 125!. The radius of rotation was 25 mm from the collimator 
with a magnifying factor of 3 employed in these studies. This setup resulted in a total 
effective view area from using two pinholes of 13.6 cm2 at the axis of rotation. The 
energy window set for gamma imaging was from 22 to 40 ke V. 
SPECT scans in this work have been acquired at 3° increments around the AOR 
for a total of 360°. Both the dwell time at each angular position and the step increment 
along the AOR may be variable and thus are stated in each specific case. We used 10 
iterations for image reconstruction in all the following studies except the hot-rod phantom 
study in which 50 iterations were used. The reconstructed images were smoothed with a 
Hann filter. No attenuation correction was applied in this work. The reconstruction used 
0.4-mm cubic voxels. 
5.2.2 Parallel-hole gamma-ray imaging 
As a reference tool, one compact gamma-ray camera described in section 3.3 was 
used for planar imaging of the phantoms. A 5 mm thick parallel-hole CuBe collimator 
with 0.55-mm square holes separated by 0.11 septa was employed in this detector. This 
collimation provides a spatial resolution about 2.5 mm FWHM on contact with the 
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collimator with an effective area of about 46 x 96 mm2. As with the circular gamma 
camera, the energy window for gamma rays was from 22 to 40 ke V. 
5.2.3 Phantom studies 
Phantom studies were carried out to evaluate the performance of two-pinhole 
helical SPECT. Each SPECT scan in the phantom studies used a dwell time of 3 minutes 
at each angular position. 
5.2.3.1 Resolution 
The same phantom and method described in section 4.7.3 were employed to 
determine the relationship between the reconstruction resolution and the number of ML-
EM iterations for two-pinhole helical SPECT. This relationship as presented in Fig. 5.7 
indicates that the overall resolution after about 10 iterations of image reconstruction is 
around 1.3 mm which is adequate for imaging the bilobal structure of the thyroid of a 
C57-derived mouse. A typical separation between the two lobes of the thyroid is about 
1.8-2.5 mm. 
To demonstrate that this measurement of resolution is reasonable, a test was 
carried out with a phantom of two parallel capillaries separated by 2 mm. The step 
increment along the AOR was 0.1 mm which was also used in the following helical 
SPECT scans of the thyroid phantom and mouse thyroid. 
As shown in Fig. 5.8, a reconstructed image from a further test demonstrates that 
two capillaries separated by 2 mm can clearly be resolved, confirming the feasibility of 
multi pinhole helical SPECT imaging of the mouse thyroid. 
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Fig. 5.7. Relationship between the reconstruction resolution (FWHM) and number of 
ML-EM iterations for two-pinhole helical SPECT 
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Fig. 5.8. (Left) A reconstructed transaxial slice (0.4 nun thickness) of the 2-capillary 
phantom. (Right) A profile along the line across the centers of the reconstructed 
capillaries in the reconstructed image of a two-pinhole helical SPECT scan. The step 
increment along the AOR is 0.1 mm. 
A further test similar to the one described in section 4.8 was carried out using the 
same ultra-micro hot rod phantom to investigate the potential of two-pinhole helical 
SPECT for resolving a more sophisticated structure with a relatively low radioactivity 
114 
concentration. The phantom contained a solution of 270 f.lCi 1251. A two-pinhole helical 
SPECT scan was obtained with step increments of 0.1 mm along the A OR. 
Even with the collimator designed for imaging small tissues such as the mouse 
thyroid and a low radioactivity concentration employed, two-pinhole helical SPECT of 
the relatively large-scale hot-rod phantom still properly resolves the wedges with rods as 
small as 1 mm in diameter and many of the 0.75 mm diameter rods can be visualized as 
well (Fig. 5.9, right). Some artifacts appear in the figure owing to multiplexing effects 
and the truncation of the phantom in projections as shown in the left panel of Fig. 5.9. 
Fig. 5.9 (left) A 3 min two-pinhole projection of the hot rod phantom. (right) A 4 mm 
thick reconstructed image of two-pinhole helical SPECT of the phantom with 3° 
increments and 3 minutes at each angular position. The step increment along the AOR 
was 0.1 mm. The phantom contained a total radioactivity of 270 f.lCi 1251 with a 
concentration of 54 f.lCi /ml. 
5.2.3.2 Sensitivity 
Single (central pinhole) and two-pinhole helical SPECT were carried out for the 
purpose of sensitivity comparison using a phantom similar to the one described in section 
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5.2.3.2. For the phantom used in this work (see Fig. 5.10), the bottom two voids are 
separated by ~ 2 mm representing the salivary glands of a mouse while the top one 
simulating the thyroid is spaced 3 mm away from them. The phantom measures 14 x 13 x 
17 mm3• Each void contains a~ 4 ~-tCi pellet (~ 12 ~-tCi in total in the phantom). This 
thyroid phantom was placed in the central region of FOV with the plane of the voids 







Fig. 5.10. (Left) Diagram of the two-pinhole collimator. The central and bottom-left 
pinholes were employed in this work. (Right) An example of a three-position thyroid-
salivary gland phantom used in this work 
The measured efficiency with the thyroid phantom is 221 cprnl~-tCi and 398 
cprnl~-tCi for one and two-pinhole helical SPECT respectively. We note that the efficiency 
is not exactly doubled for two-pinhole case owing to the fact that the sensitivity is 
proportional to (cos3B!cf) for each pinhole, where B is the gamma-ray incident angle and 
dis the perpendicular distance from the object point to the collimator [89]. 
5.2.3.3 Quantification 
After the two-pinhole SPECT scan, a parallel-hole projection of the thyroid 
phantom was acquired for 30 minutes. A sum of 14 reconstructed slices (a total of 5.6 
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mm thickness) from the two-pinhole helical SPECT scan covering the pellets region of 
the phantom was compared with the 30-min parallel-hole projection. The region of 
interest (ROI) of each pellet was analyzed with the ROI analysis program written in IDL 
language. The ROI counts of the pellets from the parallel-hole projection were compared 
with the data from the sum reconstructed image. A 25-pixel ROI (1.2 x 1.2 mm2/pixel) 
was obtained for each pellet in the parallel-hole projection while a 225-pixel ROI (0.4 x 
0.4 mm2/pixel) was used in the reconstructed SPECT image. 
The 30-min parallel-hole projection of the ~ 12 ).!Ci thyroid phantom is shown in 
the left panel of Fig. 5.11. The ROI ratio of the pellets in clockwise order starting from 
the bottom-right one is 1: 0.92: 0.94 while it is 1: 0.90: 0.99 for the reconstructed case as 
shown in the right panel of Fig. 5.11. The ratios are consistent when one takes into 
account the statistical errors arising from the low level of the isotope in the phantom. 
Both ratios show that the bottom-left pellet is the least hot indicating some 
inhomogeneous absorption of isotope. The 5.6 mm thick sum image of 14 slices of 
images covering the pellets region in the thyroid phantom indicates that the top void was 
not ideally drilled but is slightly off the median of the bottom two pellets as can be 
observed in the left planar image. The reconstructed image also shows that each~ 4 mm 
long pellet is less hot in center than at both ends presumably because the pellet 
inhomogeneously absorbed radioiodine in the solution of Na1251 due to its smooth side 
surface and rough cut ends. 
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Fig. 5.11. The experiment shown in this figure was carried out with a thyroid phantom 
that had ~ 4 11Ci in each void (a total dose of~ 12 11Ci). (Left) a 30-min parallel-hole 
projection of the thyroid phantom. (Right) the 5.6 mm thick sum image of 14 
reconstructed images from a two-pinhole helical SPECT scan covering the pellets region 
in the phantom for comparison with the left projection image. The step increment along 
the AOR is 0.1 mm. 
5.2.4 Mouse studies 
5.2.4.1 In vivo multipinhole helical SPECT 
With two-pinhole helical SPECT, we have imaged to date two mice with a 
moderate-level injection dose of 1251 and 0.1 mm step increments along the AOR. The 
first mouse was injected with 130 !-LCi Na125I and 24 hours later anesthetized and imaged 
with 2 minute dwell time at each angular position (a total of 4 hours). That mouse died in 
the 3rd hour, apparently due to the anesthesia. After the final fourth hour of imaging, the 
mouse was dissected and the thyroid tissue was measured to determine the dose level of 
the isotope and then to verify the presence of NIS protein and mRNA with the whole-
mount immunohistochemistry and RT-PCR, respectively. 
The second mouse was injected with 200 !-LCi Na1251. That mouse was 
anesthetized and imaged in vivo 24 hours later. One-minute acquisitions (a total of 2 
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hours) were obtained at each of 120 angular positions. The mouse was returned to its 
cage after the imaging to confirm that there were no effects due to the anesthetic or iodine 
dose. We compared the sum of 12 reconstructed slices (a total of 4.8 mm thickness) of 
the thyroid region with one of the 1-min projections from the two-pinhole helical SPECT, 
in which the thyroid is near the central pinhole. 
The bilobal structure of a mouse thyroid is shown in the left panel of Fig. 5 .12. As 
shown, the two lobes of the thyroid are separated by the trachea by about 1.8-2.5 mm 
depending upon their shape. The thyroid anatomical structure is well resolved by a 1.2 
mm thick coronal slice reconstructed from the 4-hour two-pinhole helical SPECT scan of 
a mouse shown in the right panel of Fig. 5.12. Measurement of the dissected mouse 
thyroid showed that about 10 1-1Ci remained in the thyroid tissue after imaging. 
Fig. 5.12. (Left) Anatomical display of the thyroid region of a mouse. (Right) A mouse 
was injected with 130!-lCi Na125I and 24 hours later anesthetized and imaged with 2-
pinhole helical SPECT for 4 hours. Although this mouse died in the third hour of imaging, 
it was possible to accumulate SPECT data throughout a four-hour period. A 1.2 mm thick 
reconstructed image on the right presents the coronal view of the mouse thyroid, 
resolving its two lobes separated about 2 mm. The physical measurement of the dissected 
thyroid tissue indicated the accumulated dose in the two thyroid lobes was ~ 1 01-1Ci in 
total. 
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Fig. 5.13. (a)-( c): A C57-derived mouse was injected with 200!-tCi Na125I and imaged in 
vivo after 24 hours for a 2-hour 2-pinhole helical SPECT scan with step increments 0.1 
mm along the AOR and 3° increments around the AOR. A 1-min projection image from 
the scan is shown in (a) with the central pinhole near the thyroid region of the mouse. 
Presented in (b) is a transaxial image ofthe thyroid region. A 4.8 mm thick sum image (c) 
of 12 coronal images fully covering the mouse thyroid region shows agreement in the 
thyroid structure with the projection image (a). Both images (b) and (c) clearly delineate 
the two lobes of the thyroid, which are separated ~ 2 mm. The physical measurement 
after imaging indicated a total of~ 20 !lCi remained in the thyroid region. (d)-(t): An 
overlay (f) of the fluorescent image (e) from NIS immunohistochemistry on the bright 
field (d) of a dissected mouse thyroid, in which the green signal indicates NIS 
localization in the thyroid lobes based on indirect staining of the anti-NIS antibody. 
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Shown in Fig. 5.13(a) is a 1-min two-pinhole projection of the thyroid region of a 
mouse injected with 200 jlCi and imaged 24 hours later in vivo. A single transaxial image 
from the two-hour, two-pinhole helical SPECT scan in Fig. 5.13(b) clearly delineates the 
bilobal structure of the mouse thyroid. Fully covering the whole thyroid region of the 
mouse, the 4.8 mm thick sum image Fig. 5.13(c) of 12 reconstructed coronal slices from 
the same helical SPECT scan indicates the consistent shape and separation of the lobes 
with the projection image in Fig. 5.13(a). Measurement after imaging shows that 
approximately 20 jlCi was still present in the thyroid of this mouse. 
5.2.4.2 Whole-mount immunohistochemistry and RT-PCR 
Whole-mount immunohistochemistry was used to localize the NIS protein in the 
thyroid. As shown in Fig. 5.13(d)-(t), immunohistostaining was used to verify the 
presence of NIS protein in the mouse thyroid. The bright field of the dissected mouse 
thyroid is shown in Fig. 5.13(d) while the fluorescent image is in Fig. 5.13(e), in which 
green signal indicates localization of the NIS protein by indirect staining of the anti-NIS 
antibody. A composite thyroid image Fig. 5.13(t) of both the fluorescent image Fig. 
5.13(e) and bright field Fig. 5.13(d) shows the green signal appears only in the lobar 
region, consistent with NIS protein expression that facilitates iodine uptake and 
metabolism. The NIS immunohistochemistry results were further supported by RT-PCR 
outcomes (data not shown), which also corresponded to 1251 uptake measured by the 
gamma camera. 
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5.2.5 Discussion and Conclusion 
In vivo molecular imaging of some tissues such as the thyroid using mice has 
significant physiological and pathological meanings. However, in vivo imaging of the 
mouse thyroid has the simultaneous requirements of high resolution and low radioactivity. 
Using phantoms, we have demonstrated in this work the capability of a multipinhole 
helical SPECT system we developed recently to meet the imaging needs in resolution, 
sensitivity and image quality for such studies. Our further animal studies have 
demonstrated that we have achieved in vivo functional imaging of the mouse thyroid with 
high performance using a relatively low level of radioactivity and two-pinhole helical 
SPECT. The efficacy of the imaging results has been validated by molecular biology data 
from both immunohistochemistry and RT-PCR. 
Our "proof-of-concept" phantom studies show that two-pinhole helical SPECT 
provides reconstructed resolution of about 1.3 mm which can accurately resolve the 
position of three voids containing a total of~ 12 )lCi in a phantom simulating the thyroid 
region. The R01 analysis of the reconstructed images shows an excellent agreement 
between the 2-D projective image and 3-D reconstructed images of the thyroid phantom. 
The test with a relatively large-scale hot-rod phantom further demonstrates that our 
system is capable of high-resolution imaging of a more sophisticated structure containing 
a low 1251 radioconcentration of 54 )lCi/ml, which is typical for actual biological studies. 
The reconstructed image from a two-pinhole helical SPECT scan of a mouse 
clearly delineates the structure of the two lobes of the mouse thyroid which are separated 
by about 2 mm. In vivo two-pinhole helical SPECT of the thyroid of an anesthetized 
mouse was successfully carried out using a relatively low dose of 1251 (200 )lCi), and an 
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imaging period of 2 hours. The summed image sufficient to cover the whole thyroid 
region shows good correlation with the pinhole projection of the mouse thyroid. The 
bilobal structure of the mouse thyroid has been further examined with ex vivo whole-
mount immunohistochemistry and the fluorescent anti-NIS indirectly localized the NIS 
protein in the dissected thyroid lobes in the same locations as the pattern of 1251 
distribution. An additional study using RT-PCR verified the correlation between the 
immunohistochemistry results and NIS mRNA expression. The molecular biology data 
have validated the in vivo multi pinhole helical SPECT imaging of the mouse thyroid and 
have further strengthened its potential for studies of other NIS-expressing tissues. 
Recently, studies have been reported in which NIS gene expression has been 
utilized for purposes of imaging or therapy of diseases such as hyperthyroidism or tumors 
[141, 142]. These studies usually require in vivo measurements of the volume and mass 
of the tissues such as the thyroid in Grave's disease for appropriate planning of 
radioiodine therapy [131, 132] or imaging the recurrent or metastatic tumors post 
treatment [127, 143]. The work we presented here suggests the potential of multipinhole 
helical SPECT in accomplishing those goals in in vivo studies using mouse models. 
In conclusion, multipinhole helical SPECT has provided the capability of in vivo 
imaging of the mouse thyroid at the molecular level using a dose of 200 ~J.Ci of 1251 and 
an imaging period of about 2 hours. This work has been verified as an NIS-dependent 
process by molecular biology techniques, i.e. immunohistochemistry and RT-PCR. 
Combining planar scintigraphy to allow quantifying and distinguishing tissue-mass voids 
and tomography for visualizing in situ living tissues, our imaging system has potential 
123 
application to molecular imaging in a variety of in vivo studies of the mouse thyroid or of 
other NIS-expressing tissues such as the stomach or mammary tumors. 
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Chapter 6 
In vivo gamma imaging in a study of mammary tumors 
Described in this chapter is the application of in vivo gamma-ray imaging in a 
study of mammary tumors using endogenous NIS expression in a mouse model and the 
novel compact gamma camera (see section 3.3) dedicated for mouse studies. The role and 
development of gamma-ray imaging in breast cancer are first introduced followed by the 
goals of this work. The methods of data acquisition and analysis are then detailed and the 
results as well. The final section includes discussion and preliminary conclusions from 
this study. 
6.1 Background 
Breast cancer is one of the most common cancers in women. There are increasing 
requirements of high-performance breast cancer imaging in current studies of this 
significant human health issue. Despite screening and diagnosis of tumors, modem breast 
cancer studies require the imaging technique to detect a tumor at its earliest stage, to 
characterize the heterogeneity of the tumor and to monitor the tumor development over 
time. The overall death rate for breast cancer has steadily declined since the early 1990s 
mainly owing to a combination of screening, improved treatment and better awareness 
[144]. Imaging techniques including mammography, MRI, ultrasonography, optical 
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imaging, and radionuclide imaging (PET and scintimammography) play a key role in this 
achievement. Each imaging technique has made its own contribution to address this 
health issue in different aspects. Mammography is the most established breast cancer 
imaging technique and the primary tool for screening and diagnosis of breast cancer. 
However, mammography has lower sensitivity in those with dense breasts [145]. 
Ultrasonography works as an adjunct to screening and diagnostic mammography. This 
technique is painless and relatively inexpensive but is highly dependent on the operator 
and has a high false-positive rate [146]. The other imaging modality as an adjunct to 
mammography is breast MRI. New breast MR imaging techniques using molecular 
markers of malignancy may help to improve tumor characterization. The limitation of 
breast MRI in specificity may lead to additional work-ups and biopsies [146]. Optical 
imaging such as near-infrared (NIR) tomography has been intensively investigated to 
detect and characterize breast cancer [147]. However, optical mammography has a major 
disadvantage of poor spatial resolution. Moreover, the in vivo optical characteristics of 
common lesions and healthy breast tissues are not yet fully known [148]. 
Radionuclide 1magmg including PET and scintimammography (planar 
scintigraphy or SPECT) has also been a significant method contributing to breast cancer 
studies. The following review indicates that radionuclide imaging has been widely 
applied in a number of studies on breast tumors and its application is usually 
accompanied with molecular techniques such as immunohistochemistry or other 
anatomical imaging modalities such as CT and MRI, etc. Both PET and 
scintimammography have presented advantages in meeting current needs for breast 
cancer research. 
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6.1.1 PET and breast cancer imaging 
Several studies have proven the accuracy of PET in detection of the primary 
tumor and axillary staging [149, 150]. F-18 fluorodeoxyglucose e8FDG), a glucose 
analog, is a standard PET radiotracer used in clinical PET imaging. The property of 
18FDG enables the analysis of the glucose metabolism and blood flow in the cancers [151, 
152]. The increased glucose metabolism of malignant breast cancer cells facilitates 
accurate differentiation of cancer from benign tissues [153]. A review shows that 18FDG-
PET presents a sensitivity value ranging between 80% and 90% and a specificity value 
between 71% and 95% in breast cancer diagnosis [154]. PET imaging has also been 
employed to make correlations between imaging and tumor parameters (lesion size, 
proliferative activity, vascularity, multidrug resistance) [155-157] or predictive and 
prognostic factors such as the estrogen receptor [158]. However, since PET images do 
not delineate fine details like a CT or MRI, the most important clinical application of 
PET currently is to determine the presence and extent of metastatic or recurrent breast 
cancer [159, 160], to evaluate multi-drug resistance [161] and to monitor response to 
therapy [162, 163]. 
Despite the obvious utility of 18FDG, additional innovative radiotracers are under 
development. Many radiotracers are aimed at more specific cellular processes in addition 
to glucose metabolism [164]. A number of studies have been carried out to investigate a 
multitude of radiotracers such as C8F]Xeloda for specific imaging of enzymes [165], 
[ 18F]FES for hormone receptor expression [166], [11C]methionine for protein synthesis 
[167], e8F]FLT for proliferation rate [167], e8F]fluoride for bone mineralization [167], 
[18F]fluoroetanidazole for hypoxia [168], etc. 
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In addition to new tracers, PET technology is also rapidly evolving. A chief 
advance is the dual-modality PET/CT scanner. Initial studies have shown the advantages 
of PET/CT over either single modality and its particular usefulness in pre-radiation 
therapy planning [ 164, 169, 170]. A series of recent studies have demonstrated the 
advantages of PET/CT in detecting multiple metastases or small tumors, monitoring the 
tumor response to chemotherapy, and accurately localizing lymph node metastasis [171-
173]. PET-MRI has been used to improve the specificity of primary breast cancer 
detection [174]. A few single-case reports indicates that PET/CT or PET/MRI may reveal 
heterogeneity of breast cancer [175, 176]. 
To improve both the sensitivity and specificity, PET dedicated to breast cancer or 
positron emission mammography (PEM) has been developed and employed as a cost-
effective alternative [177]. Several groups have proposed and evaluated the performance 
of PEM systems [178-180] and the PEM detectors based on PSPMT [177, 181-184], 
PSAPD [185-188], and CZT [186] with promising results for breast cancer imaging. 
Comparative studies have demonstrated that the clinical impact of PEM is superior to that 
of conventional gamma camera or CT [189, 190]. Studies on detection ofprimary cancer 
[191, 192] have shown excellent sensitivity and specificity. In particular, the PEM Flex 
system developed by Weinberg [177] and commercialized by Naviscan PET Systems, Inc. 
has achieved a high resolution 1.5-2 mm and demonstrated superior performance to other 
modalities, i.e. PET/CT, MRI and gamma camera [193]. The high accuracy of this system 
in primary cancer detection suggests its potential in depiction of primary breast cancer 
[194]. 
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With the advent of preclinical PET systems such as microPET and NIH Atlas 
PET, researchers are able to evaluate preclinical models of breast cancers using small 
animals with improved performance [195]. Several studies have employed MicroPET to 
image integrin, peptide nucleic acid, and multidrug resistance in addition to FDG [196-
200]. A recent report also indicates that small animal FDG-PET is a useful tool to 
monitor mammary tumor development and treatment response through longitudinal 
imaging [201]. Recent progress in developing multi-modality scanners for small animals 
has shown their potential in preclinical studies of breast cancer [202, 203]. 
As this review indicates, PET has presented its advantages in many aspects of 
breast cancer imaging. However, this technique is limited by a low sensitivity to detect 
lobular carcinoma and small tumors [151, 154]. The underlying biochemical mechanisms 
have not been fully clarified for enhanced glucose metabolism in FDG studies [204]. 
Owing to the lack of correlation with significant prognostic markers such as the tumor 
size, FDG uptake might not be used as a prognostic criterion for breast cancer studies 
[167]. Moreover, preparing the radiotracers for PET imaging may require a nearby 
cyclotron and sophisticated radiochemistry techniques [205]. 
6.1.2 Scintimammography and breast cancer imaging 
Similar to PET, scintimammography including planar scintigraphy and SPECT is 
well known as an adjunct to mammography and is effective in reducing the rates of 
negative biopsies [206]. In recent years, 99mTc-sestamibi scintimammography has shown 
a high sensitivity between 84% and 94% and specificity between 69% and 94% in the 
diagnosis of breast cancer [207]. Though scintimammography cannot substitute the 
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current primary imaging techniques for breast cancers mainly due to its low sensitivity in 
detecting breast tumors < 10 mm, it is recommended for patients with equivocal 
mammograms as well as women with dense breasts or implants. These advantages dwell 
on the fact that breast density and implants have much less effect on scintimammography 
owing to the properties of gamma rays [206, 207]. Not only for diagnosis of breast cancer, 
scintimammography plays a significant role in evaluating lymph node status and breast 
cancer metastases [208-210], predicting multidrug resistance[211, 212], assessing tumor 
response to chemotherapy [213, 214], monitoring recurrence of breast cancer [215], and 
potentially developing drugs for tumor therapy [216]. 
To date the most common tracers used in scintimammography are 99mTc-
sestamibi and 99mTc-tetrofosmin and a large body ~f studies have been carried out with 
these radiotracers [206]. Considerable effort has also been put on finding new 
radiotracers targeting antibodies or receptors on tumor cells which are suitable for 
scintimammography and potential tumor therapy [217, 218]. These radioligands include 
new EGFR inhibitors [219], Fab [220], somatostatin [221], 99mTc-NC100692 [222], anti-
HER2 affibody [223], trastuzumab [224], 67Ga-radiopharmaceutical [199], 99mTc-
EDDA/HYNIC-TOC [225], 201-thallium-cloride [226], peptide [227], tamoxifen [228], 
endoglin [229], as well as others. Researchers recently have shown interest in developing 
molecular imaging agents that are dual labeled with nuclear and optical reporters [230-
232]. These ligands can provide unique opportunities for breast cancer imaging with 
SPECT (or PET) agents and for the following intraoperative guidance with near-infrared 
(NIR) fluorophores [231]. 
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With the advances in imaging techniques, multi-modality imaging, especially 
SPECT /CT has been recently applied in breast cancer with the attempts to further 
improve the performance of scintimammography. A significant advantage of SPECT-CT 
in breast cancer is that it helps improve sentinel node identification, leading to a better 
plan of therapy [233, 234]. SPECT-CT has also shown improved sensitivity over planar 
scintigraphy [235] and has been found to be more accurate in diagnosing breast tumor 
metastases [236]. A study on breast cancer metastasis using a mouse model with 
bioluminescent imaging and SPECT /CT also indicates that multimodality imaging 
techniques can be very helpful for monitoring bone metastasis [237]. A pilot study 
demonstrated that MRI/scintimammography seems to be more accurate in measuring the 
size of breast cancer than other methods (clinical exam, mammography, MRI alone) 
[238]. 
As several reviews indicate, gamma cameras dedicated to breast cancer imaging 
may improve the accuracy of scintimammography in small breast cancer detection. 
Several groups have developed and evaluated dedicated gamma cameras based on CZT 
detectors with better visualization of objects smaller than 10 mm, suggesting the potential 
for early tumor detection [239-241]. Similar attempts have also been made with 
scintillation detectors using PSPMTs and pixellated Csi(Tl), Nal(Tl), or continuous 
LaBr3(Ce) scintillators with high spatial resolution [242-244]. Clinical systems dedicated 
for breast cancer imaging are available commercially now such as Dilon 6800 gamma 
camera for Breast-Specific Gamma Imaging (BSGI) [245] or LumaGEM digital system 
for molecular breast imaging [246]. Different collimation has been employed including 
pinhole collimator [210, 247], rotating multisegment slant-hole collimator [248], and 
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slant hole collimator [249] with improved visualization of breast lesions. Improved 
accuracy of dedicated gamma cameras in breast cancer detection has been verified in 
several reports [250-252]. 
As with PET, a variety of SPECT systems dedicated for small animals have been 
developed and some of them are available commercially such as nanoSPECT (BioScan 
Inc.), X-SPECT (Gamma Medica Inc.) and U-SPECT II (Molecular Imaging 
Laboratories). These dedicated imaging systems are being introduced into preclinical 
studies of breast cancer with promising results [211, 253]. Particularly in these attempts, 
using a high-resolution SPECT/CT system (X-SPECT), Kim eta!. were able to achieve 
detailed distribution information of a 99mTc-labeled antibody within breast tumor 
xenografts in vivo, which is consistent with ex vivo bioluminescence imaging or histology 
[253]. 
6.1.3 NIS and breast cancer imaging 
Despite the development of new ligands for breast cancer studies, researchers 
recently have shown a growing interest in the sodium iodide symporter (NIS) gene both 
as a molecular imaging reporter gene and as a therapeutic gene [142]. NIS 1s a 
transmembrane ion channel responsible for iodine metabolism. Endogenous NIS 
expression in breast tissues such as mammary glands or tumors has been confirmed by 
many groups [126, 254]. As a potential way of imaging and therapy of breast cancers, 
researchers have sought different stimulators to enhance the NIS expression in breast 
tissues [255, 256]. A multitude of agents such as, oxytocin, prolactin and tRA have been 
found to significantly induce iodide uptake, NIS mRNA or NIS protein production in 
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various cancer cell lines or in vivo. Several studies usmg either PET or 
scintimammography have suggested NIS is a promising molecule for in vivo radionuclide 
imaging of breast cancer [142, 257]. In those studies, radionuclide imaging has been used 
to verify the presence of NIS expression, to locate the NIS-expressing sites, and to 
qualitatively or quantitatively determine NIS gene expression. However, the NIS 
expression in early-stage tumors and its role for early tumor detection remains unclear. 
Moreover, NIS gene expression may also deliver detailed information such as tumor size 
and pattern in gamma images that could benefit breast cancer study for better 
understanding of breast cancer and eventually better treatment. 
6.2 Hypothesis and goals 
As Mankoff pointed out, to better detect early-stage breast cancer, we will need 
equally the development of improved instrumentation for radionuclide breast imaging 
and the development of radiotracers "designed to match the biology of early breast 
cancer" [258]. The previous studies of NIS in breast cancer and gamma-ray imaging 
technology leads us to hypothesize that the patterns of metabolic 1251 uptake presented in 
gamma images correlate with the molecular patterns of tumors as evidenced by functional 
NIS expression. This correlation would facilitate detecting the tumor at its early stage, 
investigating the parameters of the tumor, and learning the tumor progression by in vivo 
gamma-ray 1magmg. 
By combining a novel gamma camera dedicated to biological imaging and the 
unique signatures of endogenous NIS gene expression, the goals of this work are not only 
an attempt to evaluate the potential of NIS as the reporter gene for early breast tumor 
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detection using mouse models, but also an effort to characterize breast tumors and to 
monitor tumor development in vivo using NIS. Specifically, these goals include: 
1. To demonstrate the efficacy of the gamma camera in imaging MMTV mammary 
tumors by correlating the gamma images with immunohistochemical signals representing 
NIS indirectly. 
2. To demonstrate the capability of the gamma camera in detecting small tumors (<10 
mm) and monitoring mammary glands bearing no tumors. 
3. Based upon the underlying functional NIS expression in mammary tumors, to define 
the extent of known breast cancer by tumor sizes and patterns and investigate their 
correlations. 
4. To investigate the kinetic characteristics of tumors by dynamic patterns and trends of 
radiotracer uptake and evaluate their potential correlation with other tumor parameters 
5. To study tumor progression through in vivo, non-invasive imaging of the same tumor 
of the same animal over time (which consequentially requires a low dose of radioisotope). 
Our careful analysis has confirmed that the sodium iodide symporter molecular 
biology data substantiate the 1251 imaging data and demonstrate the validity of in vivo 
radionuclide imaging for mammary tumor study. We have shown the feasibility of 
gamma-ray imaging in a morphological study ofMMTV mammary tumors. Using a low-
level dose of 14 ~-tCi and confirmed by immunohistochemistry, we have demonstrated 
that sodium iodide may also potentially be a promising radiotracer for detecting non-
palpable tumors at the earliest stage (as small as 3 mm). We have identified three patterns 
of iodine distribution in MMTV tumors and found static correlations among the patterns, 
iodine uptake, and tumor size based upon a population of 40 MMTV mice exhibiting 59 
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tumors in total for a total of 69 gamma-ray imaging cases. This preclinical study has also 
shown that radionuclide scintigraphy using N a 1251 provides a promising method for in 
vivo study of morphological changes such as size and distribution pattern associated with 
tumor development, implying significant therapeutic value such as monitoring tumor 
response to pharmaceuticals over time or at different stages of development. Details 
about this study are described in the following sections. 
6.3 Animals and tumor distribution 
Animal studies were carried out with protocols approved by the WM animal 
research committee. C57BL/6J derived, MMTV -infected mice were employed for this 
study. Tumors appeared randomly and were imaged when monitored visually. 
To date, 40 MMTV mice with a total of 59 tumors have been imaged. A tumor 
was visually determined in vivo or ex vivo. As shown in the left panel of Fig. 6.1, this 
population revealed that most MMTV mice developed one (n=23, 57%) or two tumors 
(n=15, 38%). MMTV mice rarely develop more than three tumors (n=l, 5%). The 
possibilities of developing left (n=19) and right (n=20) thoracic tumors in MMTV mice 
were found to be approximately the same, 32% and 34% respectively (Fig. 6.1, right). A 
few mice developed left (n=2) or right (n=l) cervical tumors. Statistical analysis indicates 
the possibility of developing thoracic tumors (n=39, 66%) is significantly (p< 0.05) 
higher than that of inguinal tumors (n= 17, 29%). 
135 
• 2-tumor mice, 15, 
38% 
Right thoracic, 20, 
34% 
Distribution ofthe Mice Bearing Multiple Tumors 
o 3-tumor mice, 2, 
5% 
• 1-tumor mice 
• 2-tumor mice 
D 3-tumor mice 
• 1-tumor mice, 23, 
57% 
Location Distribution of the Tumors • Left cervical 
Right cervical, 1, Left cervical , 2, 
Right inguinal , 11, 
19% 
2% 3% 
Fig. 6.1 tumor distribution in the MMTV mice 
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These mice were divided into three groups. The first group (n=24) were in vivo 
imaged only once with the gamma camera. A second group (n=ll) were randomly 
selected and repeatedly imaged twice (n = 9) or three times (n=2). A third group (n=5) 
were randomly selected, imaged once and then euthanatized. Tumors and also mammary 
glands with no visual tumors were collected and studied, followed by 
immunohistochemistry for comparison with the gamma-ray images. Two sets of 
C57BL/6J female mice with no tumors served as control animals. Each set (n=3) includes 
a nulliparous, a previously lactating and a lactating mouse. After gamma-ray imaging, 
each animal was euthanatized and their mammary glands were collected for 
immunohistochemistry. 
6.4 Whole-mount immunofluorescence methodology 
Whole-mount immunofluorescence methodology was used to confirm the 
presence ofNIS protein in the tissues. The whole-mount immunohistochemistry protocol 
was slightly modified from Johnstone et al. [259]. After the processing according to the 
protocol, normal glands, control glands and tumors were visualized under a dissecting 
scope in both bright and fluorescein filtered fields. An overlay image was created using 
Adobe Photoshop 7.0. 
6.5 In vivo gamma-ray imaging of MMTV tumors 
6.5.1 Data acquisition 
We obtained all the gamma-ray images and data with the compact gamma camera 
briefly described in section 3.3. The 5 mm thick CuBe parallel-hole collimator with 0.55-
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mm square holes separated by 0.11 mm septal walls was employed in this study. This 
collimation provides an effective area of about 46 x 96 mm2 and a spatial resolution 
(FWHM) about 2.5 mm on contact with the detector surface. 
Five minutes prior to gamma-ray imaging, sodium pentobarbital was administered 
IP (intraperitoneally) as anesthetic to the animals. Each animal was then injected with 14 
f..lCi Na125I in NaOH in the femoral biceps followed immediately by one-hour imaging 
with the gamma camera. The animal was monitored and kept stable over the imaging 
period. 
The detector and related data acquisition instruments were interfaced to a 
Macintosh G3 computer via a SCSI port. Each photon detected by the gamma camera 
was referred to as an "event". A program developed with the data acquisition software 
Kmax (Sparrow, Inc.) recorded the time, energy and computationally determined 
coordinates of every event sorted into the data files. These were later transferred to a 
Macintosh G4 for further processing. 
6.5.2 Data analysis 
An analysis program developed with data processing and visualization language 
IDL (Research Systems, Inc, Boulder, Co) was used to group event files into 5-min time 
interval blocks recorded as two-dimensional matrices (referred to as "timecuts"). Each 
matrix represents a 5-min digitized gamma-ray image of that mouse. The coordinates of 
each pixel correspond to the planar position where the isotope decay is visualized in the 
mouse by the detector. The total counts stored at each pixel represent the radioactivity 
detected at that location over the 5-min interval. Another IDL-based program was used to 
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visualize the gamma-ray images and sum the total events in a designated region of 
interest (ROI) in the images. This treatment allowed time-dependent distribution analysis 
of any chosen pathological or physiological region such as tumors or mammary glands. 
Mammary glands 
We chose a square ROI with an area of 9 pixels (each pixel is 1.2 x 1.2 mm2) to 
analyze the mammary glands. In order to compare the radioactivity contained in the 
mammary glands, we normalized the values by expressing the data as a percentage of the 
total injected dose (%ID) defined by an ROI with 2880 pixels covering the entire body of 
the mouse. In evaluating the relationship between immunohistochemistry and gamma-ray 
imaging, the radioactivity accumulated from the mammary gland over the 50-55 min time 
interval was compared and correlated visually with the intensity of the NIS green signal 
in the overlay image from immunohistochemistry. 
Tumor size, radioiodine uptake and pattern 
Each tumor was analyzed with a rectangular or square ROI with variable size so 
as to fully contain the tumor without including nearby organs such as heart or salivary 
glands. In order to present the actual size and morphology of the tumor, each pixel in the 
tumor ROI was corrected by subtracting a threshold value to exclude the major 
background of radioiodine uptake due to blood flow. A threshold is the mean value per 
pixel of all the four-pixel ROis in the same abdominal or thoracic region of the mouse in 
each gamma-ray image. The usage of this threshold for blood flow correction was 
justified by the statistics indicating that the value of the threshold was in the same range 
as the radioiodine activity in the heart region 55 minutes post injection. We determined 
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the tumor size over each 5-min time interval as the total number of non-zero pixels in the 
corresponding tumor ROI with threshold subtracted and with any negative values set to 
zero. We defined the size over 50-55 min time interval as the actual size (in pixels) of the 
tumor. We regarded the total counts in the corrected tumor ROI as the net uptake of 
radioiodine in the tumor excluding the major effect of blood flow. For the purpose of 
comparing the radioactivity contained in the tumors, we again normalized these values to 
the total injected dose. 
Static correlation between the tumor size and radioactivity in the tumor over the 
50-55 min time interval was evaluated. A 13-level contour map of the corrected ROI was 
used to reveal the patterns of radioiodine distribution in the tumor over each 5-min time 
interval. We identified the radioiodine distribution pattern of each tumor and then 
associate the patterns with tumor size. 
In order to evaluate the potential correlation or association among tumor size, 
pattern, and dynamic trend of radioactivity (over the imaging period of one hour) in the 
tumor, we group the tumor size into three types: small (1-75 pixels), medium (75-150 
pixels) and large (above 150 pixels). For each type, we associated the mean dynamic 
trends of radioactivity with tumor patterns. We then correlated the trends of each pattern 
with the types. 
Difference plots 
As with the tumor pattern contour, we used contour plots of the difference 
between raw tumor ROis without threshold deduction to reveal the regions where 
radioactivity changes occurred over time. Differences were analyzed with three sets of 
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raw tumor ROis between different time intervals: 0-5 min vs. 5-10 min, 25-30 min vs. 
30-35 min, and 50-55 min vs. 55-60 min. The difference between each set of tumor ROis 
was calculated by subtracting the earlier raw tumor ROI from the later ROI. The total 
difference values were obtained and compared. The consequent positive and negative 
values (absolute values) distributed in the "difference ROis" were then visualized as both 
a positive plot (counts increase over time) and a negative plot (counts decrease over time) 
respectively. A hot region in a positive difference plot therefore implies radioiodine 
uptake while a negative plot means loss of radioactivity over that period. We divided the 
regions representing radioactivity change into central regions and edge regions. Central 
regions represent central or near-central areas within a tumor while edge regions are at 
the edge or out of the tumor area defined by the tumor ROI with threshold deducted. 
Potential trends of the change of the difference over time were analyzed and related with 
tumor pattern and/or size. 
Statistical analysis 
Linear regression analysis is used to evaluate possible correlations between 
selected data sets. When appropriate, Spearman's correlation coefficients are used to test 
for significance between some of the measured parameters. P<0.05 is considered 
statistically significant. 
6.5.3 Correlation between gamma-ray imaging and immunohistochemistry 
The prerequisite to apply our imager to this study is that we must first 
demonstrate the validity of in vivo radionuclide imaging of NIS expression in mammary 
tumors. For this purpose, we have evaluated the correlation between the data of gamma-
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ray imaging and immunohistochemistry with normal mammary glands (NMGs, n=6) of 
non-tumor-bearing C57Bl/6J mice, mammary glands bearing no visual tumors (n=5) and 
mammary tumors (n=5) of MMTV mice. Current literature suggests that NIS should only 
be expressed during lactation. A comparative study with an unrelated strain of C57 mice 
was imaged and stained for NIS to test current literature. For each set of C57 NMGs at 
different stages, we first compared their immunohistochemical result visually and then 
their ROI data from gamma-ray imaging quantitatively, followed by correlation between 
immunohistochemistry and gamma-ray imaging. For the purpose of evaluating the 
potential effect of MMTV on normal mammary glands, we semi-quantitatively compared 
the radioactivity difference between the C57 NMGs and MMTV MGs bearing no visual 
tumors. The immunohistochemical results of both the MMTV tumors and MGs with no 
visual tumors were visually correlated with their gamma-ray images. 
The results have demonstrated that the data of gamma imaging correlates 
precisely with molecular biology data from immunohistochemistry. For the strain of C57 
mice, nulliparous mice (n=2) did not incorporate 1251 in their mammary glands nor did 
they stain for NIS. Conversely, lactating C57 mice (n=2) strongly incorporated 1251 into 
lactating glands and stained highly for NIS that reflected the gamma camera image. 
Multiparous C57 mice (n=2) did not incorporate 1251 into previously lactating mammary 
glands, but when staining for the NIS one multiparous animal did have very low 
localization of the NIS and the other did not. The immunohistochemical results are well 
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Fig. 6.2. The ROis ofNMGs of two groups ofC-57 mice bearing no tumors. Each group 
includes a lactating, a previously lactating and a virgin mouse. 
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correlated with the ROI results (Fig. 6.2) from gamma-ray imaging. Based on this 
comparative study the C57 mice strain supports the literature findings that NIS is 
primarily expressed and present during lactation. 
ROI data from gamma-ray imaging indicated that associative mammary glands 
(n=5) ofMMTV tumor bearing mice on occasion incorporated 125I at higher rates than the 
NMG of C57 mice. Localization of 125I in those mammary glands can even be visually 
observed in gamma-ray images (Fig. 6.3), which was further confirmed by 
immunohistochemistry demonstrating NIS expression. Moreover, the patterning of green 
signal produced by indirect antibody staining against the NIS in MMTV tumors (n=5) 
appears highly parallel to the patterning of 125I incorporation visualized by the gamma 
camera for each tumor size. Shown in Fig. 6.3 is an example of this correlation. Two 
tumors have been confirmed in this mouse through dissection. One was a large tumor 
dissected into four pieces with the alignment as shown in the gamma image. The other 
was a non-palpable tumor with 3 mm diameter. The top-right image in Fig. 6.3 shows the 
immunohistochemical result of the dissected large tumor. That pattern of NIS expression 
correlates precisely with the pattern shown in the gamma image. The bottom-right image 
shows the correlation between gamma image and immunohistochemistry even for a 
tumor as small as 3 mm in diameter. Hence, the correlations have been verified between 
immunohistochemistry and scintigraphy of C57 NMGs, associative MGs and tumors of 
MMTV mice, leading to the assumption that the usage of radionuclide imaging is valid in 
studying molecular activities associated with NIS-expressing MMTV tumors. 
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Fig. 6.3. Correlation between gamma image and immunohistochemistry. (Left panel) 
gamma planar image of a MMTV -infected mouse bearing one large thoracic tumor in the 
left and one small non-palpable inguinal tumor in the right. The large tumor was 
dissected according to the alignment in the gamma image. (Right panel) top, 
immunohistochemical data of the dissected large tumor; middle, the right inguinal 
mammary gland bearing no visual tumors as the control; bottom, immunohistochemical 
data of the small tumor measuring 3 mm in diameter. The green signal produced by 
indirect antibody staining against the NIS demonstrates the presence and pattern of NIS 
expression in the mammary tumors. 
6.5.4 Results of gamma-ray imaging 
Following the validation of efficacy of our system for gamma-ray imaging of 
MMTV tumors, we have analyzed the data of all applicable imaging cases and evaluated 
the performance of gamma-ray imaging in studying mammary tumors. Accordingly, the 
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significant parameters of interest have been investigated including radiotracer distribution 
in a tumor, tumor size and pattern, and potential association/correlation among those 
parameters. 
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Fig. 6.4. Distribution of times for 125I to reach the maximum tumor size within one hour 
6.5.4.1 Time for full-size distribution of iodine in MMTV tumors 
R01 analysis shows that 1251 reaches maximum distribution in MMTV tumors at a 
variety of times after the injection of radioactivity. Shown in Fig. 6.4 is the statistical 
diversity of time for 1251 to distribute everywhere (maximum tumor size) in a MMTV 
tumor though about 45% of the tumors (n=31) present full tumor-size distribution during 
the period of 20-30 minutes post injection. The distribution of radioiodine in seven 
tumors was relatively slow and continued even during the period of 55-60 minutes post 
injection. After analyzing all time cuts for imaged tumors the 50-55 minute range 
reflected well maximum tumor dispersal and thus tumor size. 
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(a) Center-to-edge pattern 
(b) Multi-spot pattern 
(c) Ring pattern 
Fig. 6.5. Three typical patterns of 125I distribution in MMTV tumors 
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6.5.4.2 Three patterns of 1251 distribution in MMTV tumors 
We have identified three patterns of 1251 distribution in the tumors from the 69 
imaging cases: center-to-edge (n=24), multi-spot (n=31) and ring (n=4). The center-to-
edge pattern as shown in Fig. 6.5a initially presents localization of radioiodine in one 
region. With that region as the center, radioiodine distribution expands nearby and then to 
farther regions until the whole tumor is fully distributed with 125!. For the multi-spot 
pattern presented in Fig. 6.5b, tumors initially present localization of radioiodine at one 
or more spots and then at other spots and/or their nearby regions. The ring pattern (Fig. 
6.5c) is a special case of multi-spot pattern when the multi spots form a ring shape. We 
treat ring-pattern tumors as multi-spot tumors in the following analysis because of the 
small number of samples and similar behaviors as the latter. 
6.5.4.3 Relationship among tumor patterns, size, and 1251 uptake 
Results also indicate that there is an association/correlation among tumor patterns, 
size and uptake of 1251 over the 50-55 min interval. Revealed in Fig. 6.6 is that center-to-
edge pattern associated with the tumors with small size ( < 7 5 pixels in area where one 
pixel is 1.2 mm x 1.2 mm) while medium (76-150 pixels in area) and large tumors(> 150 
pixels in area) are all multi-spot pattern. The overall accumulation of 1251 in a tumor 
increases as the tumor size increases. Further analysis shows that 1251 level in the small-
size tumors during the period of 50-55 min post injection demonstrates a significant 
correlation between 1251 uptake and tumor size (Fig. 6.7, left; r2 = 0.553, p<0.05). The 
moderate-size tumors present a correlation with the size, but not significant (Fig. 6. 7, 
middle; r2=0.3392, p>0.05). No correlation is found between uptake in the large tumors 
and size (Fig. 6.7, right; r2 =0.0406). 
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Fig. 6.6 Correlation among tumor patterns, size and 1251 uptake during 50-55 minutes 
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Fig. 6.7 Correlations between the 1251 uptake and tumor s1ze: (left) small; (middle) 
moderate; (right) large 
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We find no overall association of tumor patterns with the mean dynamic trends of 
1251 uptake (n = 9 for each catalog of tumor size). However, for the small-size tumors, 
mean iodine uptake (n= 9, Fig. 6.8, top) is much higher for the center-to-edge pattern 
than for the multi-spot pattern even though the tumors in these two catalogs have 
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Fig. 6.8. Respective comparison of dynamic 1251 uptake (top) and size (bottom) between 
center-to-edge and multi-spot patterns. 
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mm 
(b) 50_55 min vs. 55_60 min 
Fig. 6.9. Difference plots at beginning and ending periods of imaging 
6.5.4.4 Difference plots 
The difference plots revealed that the most activity change, usually 1251 
accumulation, appeared in the first ten minutes post injection as shown in Fig. 6.9a. The 
regions in the difference plots presenting the greatest local change of 1251 activity usually 
happen at or very near the regions that initially were very active in 1251 uptake. This 
change may also appear at the regions or their vicinity that previously had the locally 
greatest activity change. Negative plots indicate that significant loss of 1251 from some 
regions of the tumor usually appears during the last period of imaging (30-60 minutes, 
Fig. 6.9b ). The dynamic trend of positive/negative area corresponding to radioiodine 
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uptake/loss in that period was correlated with the trend of net counts difference. A variety 
of trends during the same period of time (30-60 minutes) indicated the diversity of the 
appearance of local positive/negative regions presenting the uptake/loss of radioiodine. 
However, no association/correlation of these trends was found with tumor patterns or 
sizes. The analysis results indicate that the regions eventually losing 125I in most tumors 
(n=48 out of 67) were in both central and edge area of the tumor. 
6.5.5 In vivo gamma-ray imaging and tumor development 
In vivo imaging facilitates repetitive study of the same tumor in the same animal. 
Therefore, we employed gamma-ray imaging to monitor the tumor development over 
time. The MMTV mice (n=ll) in the second group were imaged repeatedly with time 
intervals from four to 27 days. We evaluated the change of tumor size over time and 
correlated it with the change of total radioactivity in the entire tumor and the change of 
mean counts per pixel of the tumor respectively. The size change owing to tumor 
development was further associated with the possible pattern change. Moreover, we 
investigated the potential relationship of the tumor location with tumor development. 
Two MMTV tumors had no detectable size change for time i~tervals from six to 
27 days while the rest of the tumors (n = 9) increased their size by 45-185% after four to 
21 days with tumor development. These changes are positively associated with the 
changes of radioactivity of 125I in the entire tumors (Table. 6.1 ). The tumors with no 
detectable change of size had no substantial change of total radioactivity while those 
developing their size increased the total uptake of 125!. However, we found no clear 
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correlation between the change of tumor size and the change of mean counts per pixel of 
a tumor representing the average level of the NIS expression in the tumor. 
Imaging date post Tumor Pattern Tumor size 125I uptake in the 
injection (days) (pixels) entire tumor 
0 Center-to-edge 24 0.00477 
14 Center-to-edge 52 0.01284 
35 Multi-spot 107 0.01918 
Table 6.1. Repeated imaging of a right thoracic tumor 
The results based on the limited samples (n = 11) show no relationship between 
the speed of tumor development and the initial size or pattern of the tumor. Both initially 
small and large tumors can develop their size rapidly. Pattern change (n=2) was observed 
from center-to-edge to multi-spot for initial tumors with a small size. Tumor location was 
not found to be related to these conclusions. In summary, radionuclide scintigraphy is a 
promising method for in vivo study of morphological changes such as size and 
distribution pattern associated with tumor development. 
6.6 Discussion and conclusion 
In an attempt to address the needs of high-performance breast cancer imaging, we 
have investigated in this study the application of in vivo gamma ray imaging for breast 
cancer study using a novel gamma camera and endogenous NIS expression in a mouse 
model. We have validated in this work the efficacy of in vivo gamma imaging of MMTV 
tumors with NIS as the reporter gene through molecular biology assay 
immunohistochemistry. We have demonstrated the capability of the dedicated gamma 
camera in detecting tumors as small as 3 mm and monitoring mammary glands bearing 
no visual tumors. Based upon analyzing the gamma images of endogenous NIS 
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expression in the mammary tumors of MMTV -infected mice, we have determined the 
sizes, patterns and radioactivity of the known tumors and the correlations among those 
parameters. We have also investigated the dynamic patterns and trends of radioactivity of 
the tumors over the one-hour imaging period and their relationship with other tumor 
parameters. We have finally shown the feasibility of in vivo gamma imaging for the study 
of tumor development over time through the same tumor of the same animal using a 
relatively low dose (14 ~-tCi) of 1251. The results suggest that the combination of a 
dedicated gamma camera and endogenous NIS expression has great promise to meet 
current imaging requirements for breast cancer studies. 
Our results show that gamma images correlate with immunohistochemistry data 
not only for moderate tumors but also tumors as small as 3 mm. This is a significant 
achievement because small tumors usually have less NIS expression than larger tumors 
and thus may take up only a small amount of radioactivity for gamma imaging. As shown 
in Fig. 6.3, our dedicated gamma camera clearly shows localization of 1251 in both the 
large and small tumors. The 3 mm diameter small tumor (Fig. 6.3) was actually non-
palpable until we confirmed it after the mouse dissection. Interestingly, we also notice 
that the mammary glands bearing no palpable tumors of over 50% MMTV -infected mice 
presented localization of radioiodine. Owing to the limited opportunity of dissection for 
confirmation, it remains unclear whether these mammary glands contain tiny tumors or 
not. Whether this phenomenon results from underlying biological issues related to 
MMTV is also of interest for further studies. However, these results have strongly 
suggested the advantage of our dedicated gamma camera for detecting a breast tumor at 
its earliest stage using NIS as the reporter gene. 
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We have evaluated the relationship among the tumor parameters such as sizes, 
patterns and radioactivity. As many other studies have done, we have correlated the 
tumor size with the total radioactivity in the tumor. We have found a similar general 
relationship that larger tumors accumulate more radioactivity. In addition to that, we 
learned that the small tumors present a relatively stronger correlation with their sizes 
while larger tumors have little or no significant relationship with tumor sizes. These 
results imply that the role of biological parameters beyond size is becoming more 
important in affecting the uptake of radioactivity in tumors with increasing size. Our 
study further reveals tumor patterns and the association with tumor sizes. We have 
identified three patterns of MMTV tumors with tumor size, i.e. center-to-edge (type I), 
multi-spot and ring (type II). These two types of tumors are associated with tumor size 
below and above 75 pixels, respectively. Though the manner in which these types of 
tumors are related to their biological properties requires further investigation, these 
results clearly suggests the feasibility of characterization of such tumors using in vivo 
gamma 1magmg. 
Our study also indicates a possible way to reveal radioiodine transfer in the tumor 
by referring to the positive and negative difference plots. Presented in Fig. 6.10 is a 
presumed pathway for iodine transfer in a tumor with center-to-edge pattern: 
1. Initial uptake of 125I via NIS expression of the active tumor tissues; 
2. Adjacent tumor tissues become hot with 125I transferred from central regions; 
3. 125I transfer continues from the near-central regions to edge regions 
Our preliminary study of tumor progression shows a possible association between the 
development of a small tumor and the change of tumor pattern. We have also found 
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Fig. 6.1 0. Presumed pathway for iodine transfer in a tumor. (Top row:) Uptake of 125I via 
NIS expression of the active tumor tissues in the first ten minutes post injection of 
radiotracers; (Middle row:) adjacent tumor tissues become hot with 125I transferred from 
central regions in the period of 25-35 minutes post injection; (Bottom row:) 125! transfer 
continues from the near-central regions to edge regions in the period of 50-60 minutes. 
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that the diversity of the speed of tumor development has no clear relationship with the 
initial size of the tumor. Though this study was limited by the sample size and a large 
sample size may provide more comprehensive results, the results indicate that gamma 
imaging with a dedicated gamma camera is a promising in vivo method of monitoring the 
morphological changes associated with tumor development. 
In conclusion, we have demonstrated that in vivo gamma 1magmg usmg a 
dedicated gamma camera with NIS as the reporter gene is very promising for breast 
cancer studies based upon mouse models. Specifically, we have confirmed the efficacy of 
gamma imaging of mammary tumors by correlating the distribution of 1251 observed in 
gamma images with the data of immunohistochemistry. We have found that NIS is an 
effective reporter gene for detecting a tumor at its earliest stage. Based on this reporter 
gene, we have identified three patterns of 1251 distribution in tumors, i.e. center-to-edge, 
multi-spot and ring, which are associated with tumor sizes. Our study particularly shows 
that the total 1251 uptake in a tumor has little or no significant correlation with increasing 
tumor size. The dynamic changes of pattern and trends of 1251 uptake in a tumor suggest a 
possible way to reveal the pathway of 1251 transfer in the tumor. Our preliminary results 
also indicate that the imaging method we proposed here has the potential for a range of 
studies of tumor development. 
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Chapter 7 
Future directions and conclusion 
7.1 Future directions 
We have developed a versatile imaging system suitable for biological studies 
using small animals. Our collaboration is pursuing further extension of the capabilities of 
this system in three directions: development of a relatively large field-of-view detector 
interchangeable for parallel-hole or pinhole imaging, incorporation of a mouse 
monitoring system, development of computer-aided pattern recognition program for 
image analysis of mammary tumors. 
7.1.1 Development of a novel LaBr3 detector 
One major improvement we are achieving is the development of a novel high-
performance detector readily adaptable to parallel-hole and pinhole SPECT thus meeting 
the different requirements of a variety of biological studies using small animals such as 
mice or rats. The new flat-panel PSPMT, Hamamatsu H9500, has become available 
recently. The H9500 PSPMT has an external size of 52 mm x 52 mm x 33.3 mm with an 
effective view area 49 mm x 49 mm and a 1.5 mm glass window, which results in only a 
small dead space between adjacent tubes. A matrix of 16 x 16 anode pads is utilized in 
this module with anode pitch of 3 mm in both directions. Therefore, H9500 PSPMTs 
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provide better spatial resolution than the earlier H8500 modules from the same 
manufacturer. The quantum efficiency of the H9500 is also good, i.e. 24% at 420 nm. 
These properties make the H9500 PSPMT an excellent choice for developing a new 
detector for small animal imaging. This new tube has demonstrated its applicability to 
gamma-ray imaging [72, 260-263]. Several research groups have carried out studies on 
this tube and have reported on its suitability and feasibility for nuclear medicine imaging 
applications. Inadama et al. [262] and Imrek eta!. [261] have demonstrated the suitability 
of this PSPMT when applied to PET imaging of small animals. The simulations and 
preliminary measurements reported by Garibaldi et al. suggest the feasibility of high-
performance gamma-ray detectors for early diagnosis and therapy monitoring of breast 
cancer built from arrays of smaller anode pixel size PSPMTs such as H9500 using their 
new multi-channel electronics [260]. Our collaborators, Popov et al. and Proffitt et a!. 
have developed high-performance readout electronics and high-rate USB data acquisition 
system suitable for the application of H9500 PSPMTs in PET and SPECT imaging, 
respectively [72, 263]. These studies indicated that it was promising to design a high-
performance detector based on the H9500. As to scintillators, lanthanum bromide (LaBr3) 
has shown very promising characteristics as a gamma-ray imager and spectrometer. The 
excellent energy resolution of LaBr3 (6% at 140 keV and ~3% FWHM at 662 keV) 
makes it the major competitor of semiconductor detectors working at room temperature. 
LaBr3 scintillator also has high light yield (63000 photons/MeV), flat response as a 
function of incident gamma energy and short scintillation decay time (16ns). These 
features satisfy the principal requirements for gamma-ray imaging such as high light 
output, high photo-fraction and excellent energy resolution [264, 265]. Several groups 
160 
have proposed LaBr3 detectors for gamma-ray imaging [74, 264, 266]. The report on 
recent advances and future perspectives of gamma imagers for scintimammography by 
Pani et al. [264] indicated that a LaBr3(Ce) gamma camera showed superior spatial and 
energy resolution compared with a previous camera based on a Nal(Tl) scintillator array. 
Despres et al. investigated a PSAPD-based gamma camera using continuous crystals 
including LaBr3(Ce) [74]. Their results suggest that the continuous crystal configuration 
is especially well suited for a small-animal imaging system. A study by Yamamoto et al. 
confirmed that LaBr3(Ce) is promising for low-energy gamma-ray imaging [266]. 
Building upon those reported results, we have designed a novel detector that is 
suitable for either parallel-hole or multipinhole SPECT. Shown in Fig. 7.1 is a 
photograph of the integrated detector including scintillator, PSPMTs and electronics. This 
detector incorporates a single piece of 3 mm thick continuous LaBr3(Ce) scintillator and 
an array of 2 x 2 Hamamatsu H9500 PSPMT modules. High-performance readout 
electronics and high-rate USB data acquisition system have been employed for this 
detector [72, 263]. The preliminary test shows that the intrinsic resolution of the detector 
is around 0.7 mm for 166 keV gamma rays. Owing to the relatively large sensitive area of 
100 x 100 mm2, the detector (if equipped with parallel-hole collimator) will allow us to 
image a pair of mice simultaneously for immediate comparison of their response to 
radiotracers. Multipinhole collimators can also be easily employed in this detector to 
enable relatively large field-of-view multipinhole circular or helical SPECT with a goal 
of improved performance. 
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Fig. 7.1 Photographs ofthe prototype LaBr3(Ce) detector 
Currently we can achieve spatial resolution of 1.2-1.5 mm for multipinhole (up to 
five 1 mm diameter pinholes) circular/helical SPECT using a 110 mm diameter circular 
detector. However, submillimeter resolution would allow us to resolve better the fine 
structure of the tissues we are studying. The novel LaBr3 detector will make it easier to 
further improve the resolution of our multipinhole circular/helical SPECT system. An 
effective way to improve the resolution is to reduce the diameter of the pinhole, which 
consequently reduces the sensitivity of the detector. The relatively large sensitive area of 
the LaBr3 detector enables us to use more pinholes to compensate for the loss of 
sensitivity due to the reduced pinhole diameter. 
7.1.2 Mouse anesthesia vital sign monitoring system improvement 
To optimize imaging conditions for animal subjects, several changes in current 
procedures can be envisioned. They could involve the use of gas anesthesia and 
continuous vital sign monitoring. Future development of this capability is expected as we 
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modify a veterinary monitoring system (Arc 2000, Silogic International Ltd.) and a 
heated anesthetizing gas flow system. The improvement is called in progress in our lab. 
7.1.3 Computer-aided pattern recognition for tumor studies 
In the ongoing study of mammary tumors using MMTV -infected mice, we have 
concluded that it is important to determine the pattern of each individual tumor and to 
correlate that pattern with other parameters such as size or stage of development in order 
to produce an illustrative relationship which may imply biological information for 
researchers. In the imaging study of MMTV tumors as described in Chapter 6, we 
determined tumor patterns visually. With the advances in computer science, a variety of 
computer-aided methods of image analysis have been developed for different imaging 
modalities. Segmentation of ROI (in mammography) [267] or volume of interest (VOl in 
PET and SPECT) [201, 268] are significant to determine the morphological 
characteristics for pattern recognition and for quantitative, objective analysis of the target 
tissues. The segmentation method in dynamic scintigraphy [269] producing a functional 
image representing regions with temporal dynamics, seems interesting though it has been 
proposed for dynamic cardiac imaging. Researchers use a combination of observers such 
as radiologists and physicians for visual pattern determination and semi-quantitative 
methods such as standardized uptake value (SUV) to classify patterns in PET imaging 
data [270]. An alternative approach to evaluate the heterogeneity of tissues in images is 
to use the quantitative output scores of image analysis techniques, i.e. automated 
quantitative analysis (AQUA) score [271], fractal dimension [272], or artificial neural 
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networks (ANNs) output [273]. It is likely, therefore, that there is potential in applying 
some of these pattern recognition techniques to image analysis of MMTV tumors. 
7.2 Conclusion 
A compact imaging system equipped with novel detectors suitable for biological 
imaging of small animals has been developed. This versatile apparatus is capable of dual-
modality (gamma ray/X-ray) planar imaging, parallel-hole SPECT, and multipinhole 
circular/helical SPECT. In particular, we have developed compact gamma cameras for 
biological imaging based upon newly available PSPMT modules. We have recently 
extended this system to be capable of multi pinhole helical SPECT based on a 110 mm 
diameter circular detector. The efficacy of this effort has been verified with a number of 
phantom and mouse studies. This imaging system has further been applied to several 
biological studies including mouse thyroid and mammary tumors. Results demonstrate 
that this work can readily meet a number of different requirements for a variety of small 
animal imaging applications. This compact, high-performance imaging system is not only 
suitable for in vivo small animal research as evidenced by the applications described here 
but its modular construction will allow expansion and further development as new needs 
and new opportunities arise. 
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